Processing 00000000.tx.1: Familial ATTR amyloidosis: microalbuminuria as a predictor of symptomatic disease and clinical nephropathy Lusa Lobato1,2,3,, Idalina Beiro1,3, Manuela Silva1, Fernanda Bravo4, Frederico Silvestre5, Serafim Guimares1, Alda Sousa2,3,6, Laure-Hlne Nol7 and Jorge Sequeiros2 1 Department of Nephrology, Hospital Geral de Santo Antnio, Porto, 2 Institute for Molecular and Cell Biology, Porto, 3 Centro de Estudos de Paramiloidose, Porto, 4 Department of Clinical Pathology, Hospital Geral de Santo Antnio, Porto, 5 Department of Pathology, Hospital Geral de Santo Antnio, Porto, 6 Department of Population Studies, ICBAS, Universidade do Porto, Portugal and 7 Service de Nephrologie, Hpital Necker, Paris, France  Abstract Top Abstract Introduction Subjects and methods Results Discussion References  Background.

Phrase: "Familial ATTR amyloidosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0740340:Amyloidosis, Familial [Disease or Syndrome]
   827   C0002726:Amyloidosis [Disease or Syndrome]

Phrase: ":"

Phrase: "microalbuminuria as a predictor of symptomatic disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "and"

Phrase: "clinical nephropathy Lusa Lobato1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ", Idalina Beiro1,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "Manuela Silva1,"

Phrase: "Fernanda Bravo4,"

Phrase: "Frederico Silvestre5,"

Phrase: "Serafim Guimares1,"

Phrase: "Alda Sousa2,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "6,"

Phrase: "Laure-Hlne Nol7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1427266:NOL7 [Gene or Genome]

Phrase: "and"

Phrase: "Jorge Sequeiros2 1 Department of Nephrology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0587474:Nephrology department [Health Care Related Organization]
   753   C1704729:Department [Organization]

Phrase: "Hospital Geral de Santo Antnio,"

Phrase: "Porto,"

Phrase: "2 Institute for Molecular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "Cell Biology,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Porto,"

Phrase: "3 Centro de Estudos de Paramiloidose,"

Phrase: "Porto,"

Phrase: "4 Department of Clinical Pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0587487:Pathology department [Health Care Related Organization]
   760   C1704729:Department [Organization]

Phrase: "Hospital Geral de Santo Antnio,"

Phrase: "Porto,"

Phrase: "5 Department of Pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0587487:Pathology department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "Hospital Geral de Santo Antnio,"

Phrase: "Porto,"

Phrase: "6 Department of Population Studies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "ICBAS,"

Phrase: "Universidade"

Phrase: "do"

Phrase: "Porto,"

Phrase: "Portugal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032729:Portugal [Geographic Area]

Phrase: "and"

Phrase: "7 Service de Nephrologie,"

Phrase: "Hpital Necker,"

Phrase: "Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: "France  Abstract Top Abstract Introduction Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   766   C0681850:Subject [Group]
   766   C1550501:{Subject} [Idea or Concept]
   766   C1706203:Subject [Idea or Concept]
   766   C2349001:Subject [Human]
   766   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Background."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706907:Background [Conceptual Entity]
Processing 00000000.tx.2: Portuguese type familial amyloid polyneuropathy (FAP) is a neuropathic amyloidosis caused by a mutant transthyretin (TTR). 

Phrase: "Portuguese type familial amyloid polyneuropathy (FAP)"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   924   C0268384:Portuguese type amyloid polyneuropathy [Disease or Syndrome]
   884   C0206245:Familial amyloid polyneuropathy [Disease or Syndrome]
   884   C2751492:AMYLOID POLYNEUROPATHY, FAMILIAL [Disease or Syndrome]
   853   C0751448:Polyneuropathy, Familial [Disease or Syndrome]
   840   C0206247:Amyloid polyneuropathy [Disease or Syndrome]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0015576:familial [Family Group]
   804   C0032730:Portuguese [Population Group]
   804   C0152025:Polyneuropathy [Disease or Syndrome]
   804   C0241888:Familial [Functional Concept]
   804   C0332307:Type [Qualitative Concept]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1547052:*Type [Quantitative Concept]
   733 E C1704727:Family [Conceptual Entity]

Phrase: "is"

Phrase: "a neuropathic amyloidosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268384:AMYLOIDOSIS, NEUROPATHIC [Disease or Syndrome]
   861   C0002726:Amyloidosis [Disease or Syndrome]

Phrase: "caused by a mutant transthyretin (TTR)."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0032923:Transthyretin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C1421224:TRANSTHYRETIN [Gene or Genome]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.3: Varying degrees of renal involvement have been reported. 

Phrase: "Varying degrees of renal involvement"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0449290:Degree of involvement [Qualitative Concept]
   760   C0449286:degrees [Quantitative Concept]
   760   C0542560:degrees [Intellectual Product]
   726 E C0441889:Degree [Qualitative Concept]
   726 E C1561545:degree [Quantitative Concept]
   726 E C2348088:Degree [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.4: Our aim was to assess the value of microalbuminuria (MA) for predicting clinical neurological disease and overt nephropathy in TTR-related amyloidosis. 

Phrase: "Our aim"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1947946:Aim [Idea or Concept]
  1000   C2948600:Aim [Pharmacologic Substance]
  1000   C3540471:AIM [Gene or Genome]
  1000   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the value of microalbuminuria (MA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1522609:Value [Quantitative Concept]

Phrase: "for predicting clinical neurological disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0027765:neurological disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "overt nephropathy in TTR-related amyloidosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0022658:Nephropathy [Disease or Syndrome]
   748   C0268382:Nephropathic amyloidosis [Disease or Syndrome]
Processing 00000000.tx.5: Methods.All subjects had the TTR Val30Met mutation, and were recruited between 1993 and 1999. 

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "All subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "had"

Phrase: "the TTR Val30Met mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "were"

Phrase: "recruited between 1993"

Phrase: "and"

Phrase: "1999."
Processing 00000000.tx.6: We have prospectively evaluated 22 asymptomatic gene carriers (7 male, 15 female; mean age 41.69.6 years) and 32 patients with neuropathy (14 male, 18 female; 36.88.8 years, on average, 33.09.3 years at the onset of neuropathy). 

Phrase: "We"

Phrase: "have"

Phrase: "prospectively"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "22 asymptomatic gene carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0007294:carriers [Finding]
   779 E C0560175:Carrier [Finding]
   779 E C1706209:Carrier [Medical Device]
   779 E C3273162:Carrier [Intellectual Product]

Phrase: "(7 male,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0024554:Male [Finding]
   861   C0086582:male [Population Group]
   861   C1706180:Male [Qualitative Concept]
   861   C1706428:Male [Qualitative Concept]
   861   C1706429:Male [Organism Attribute]

Phrase: "15 female"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0015780:Female [Finding]
   861   C0043210:female [Population Group]
   861   C0086287:female [Population Group]
   861   C1705497:Female [Qualitative Concept]
   861   C1705498:Female [Qualitative Concept]

Phrase: "; mean age 41.69.6 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   876   C1510829:Age-Years [Temporal Concept]
   799   C0439234:years [Temporal Concept]
   766 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "32 patients with neuropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:Patients [Patient or Disabled Group]

Phrase: "(14 male,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0024554:Male [Finding]
   861   C0086582:male [Population Group]
   861   C1706180:Male [Qualitative Concept]
   861   C1706428:Male [Qualitative Concept]
   861   C1706429:Male [Organism Attribute]

Phrase: "18 female"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0015780:Female [Finding]
   861   C0043210:female [Population Group]
   861   C0086287:female [Population Group]
   861   C1705497:Female [Qualitative Concept]
   861   C1705498:Female [Qualitative Concept]

Phrase: "; 36.88.8 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]

Phrase: "on average,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510992:Average [Quantitative Concept]
  1000   C2825518:AVERAGE [Quantitative Concept]

Phrase: "33.09.3 years at the onset of neuropathy"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C3274945:Year of Onset [Temporal Concept]
   742   C0439234:years [Temporal Concept]
   708 E C0439508:/year [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.7: We measured urinary albumin excretion every year, if asymptomatic, or every 6 months if already affected. 

Phrase: "We"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "urinary albumin excretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0042027:Urinary [Body Part, Organ, or Organ Component]
   827   C0221102:Excretion [Physiologic Function]
   827   C0504085:Excretion [Body Substance]
   827   C1524119:urinary [Qualitative Concept]
   827   C2699704:EXCRETION [Regulation or Law]

Phrase: "every year,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439234:year [Temporal Concept]
  1000   C0439508:/year [Temporal Concept]

Phrase: "if"

Phrase: "asymptomatic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231221:Asymptomatic [Finding]

Phrase: "or"

Phrase: "every 6 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "if"

Phrase: "already"

Phrase: "affected."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]
Processing 00000000.tx.8: Kidney biopsies were performed in patients with normal urinary albumin excretion, MA, and overt nephropathy, respectively. 

Phrase: "Kidney biopsies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0194073:Kidney biopsy [Diagnostic Procedure]
   861   C0005558:biopsies [Diagnostic Procedure]
   827 E C0220797:biopsy [Functional Concept]

Phrase: "were"

Phrase: "performed in patients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "with normal urinary albumin excretion,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C0860865:normal albumin [Finding]
   812   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0042027:Urinary [Body Part, Organ, or Organ Component]
   812   C0221102:Excretion [Physiologic Function]
   812   C0504085:Excretion [Body Substance]
   812   C1524119:urinary [Qualitative Concept]
   812   C2699704:EXCRETION [Regulation or Law]

Phrase: "MA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "and"

Phrase: "overt nephropathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022658:Nephropathy [Disease or Syndrome]

Phrase: "respectively."
Processing 00000000.tx.9: Results.In asymptomatic carriers, persistent MA was detected in eight (36%) subjects. 

Phrase: "Results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "In asymptomatic carriers,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007294:carriers [Finding]
   861   C0231221:Asymptomatic [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "persistent MA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "was"

Phrase: "detected in eight"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205454:Eight [Quantitative Concept]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(36%"

Phrase: ")"

Phrase: "subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]
Processing 00000000.tx.10: The presence of MA in asymptomatic gene carriers, compared with those having normal urinary albumin excretion, conferred a 4.8-fold risk of developing neuropathy, usually within the subsequent 3 years. 

Phrase: "The presence of MA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in asymptomatic gene carriers,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0007294:carriers [Finding]
   793 E C0560175:Carrier [Finding]
   793 E C1706209:Carrier [Medical Device]
   793 E C3273162:Carrier [Intellectual Product]

Phrase: "compared with those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "having"

Phrase: "normal urinary albumin excretion,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C0860865:normal albumin [Finding]
   812   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0042027:Urinary [Body Part, Organ, or Organ Component]
   812   C0221102:Excretion [Physiologic Function]
   812   C0504085:Excretion [Body Substance]
   812   C1524119:urinary [Qualitative Concept]
   812   C2699704:EXCRETION [Regulation or Law]

Phrase: "conferred"

Phrase: "a 4.8-fold risk of developing neuropathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0035647:Risk [Qualitative Concept]

Phrase: "usually within the subsequent 3 years."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0332282:Subsequent [Temporal Concept]
   753   C0439234:years [Temporal Concept]
   719 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.11: Once neurological signs appeared, nephropathy, manifested as MA, progressed to overt nephropathy in one-half of subjects. 

Phrase: "Once neurological signs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0220912:signs [Functional Concept]
   827   C0220913:signs [Manufactured Object]
   827   C0311392:SIGNS [Finding]
   793 E C1547188:Sign [Idea or Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: ","

Phrase: "nephropathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022658:Nephropathy [Disease or Syndrome]

Phrase: "manifested as MA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205319:manifested [Functional Concept]
   790   C0730345:Microalbuminuria [Disease or Syndrome]
   790   C1280444:manifested [Qualitative Concept]

Phrase: "progressed to overt nephropathy"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0022658:Nephropathy [Disease or Syndrome]
   770   C1272688:progressed [Functional Concept]
   737 E C1280477:Progress [Functional Concept]

Phrase: "in one-half"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2825407:Half [Quantitative Concept]

Phrase: "of subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]
Processing 00000000.tx.12: In patients with neuropathy, 24 (75%) had MA during follow-up: evolution towards clinical renal disease occurred in 14 (58%) and renal failure occurred in five (21%), always after a course of MA. 

Phrase: "In patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with neuropathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "24"

Phrase: "(75%"

Phrase: ")"

Phrase: "had"

Phrase: "MA during follow-up"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: ":"

Phrase: "evolution towards clinical renal disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0015219:Evolution [Genetic Function]

Phrase: "occurred in 14"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1709305:Occurred [Activity]
   756 E C2745955:OCCUR [Temporal Concept]

Phrase: "(58%"

Phrase: ")"

Phrase: "and"

Phrase: "renal failure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035078:Renal Failure [Disease or Syndrome]
  1000   C1963154:Renal failure [Finding]
   861   C0022646:Renal [Body Part, Organ, or Organ Component]
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "occurred in five"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205451:Five [Quantitative Concept]
   790   C1709305:Occurred [Activity]
   756 E C2745955:OCCUR [Temporal Concept]

Phrase: "(21%"

Phrase: ")"

Phrase: ","

Phrase: "always after a course of MA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0730345:Microalbuminuria [Disease or Syndrome]
   753   C0750729:Course [Temporal Concept]
   753   C2003902:Always [Temporal Concept]
Processing 00000000.tx.13: Proteinuria or renal failure without prior persistent MA were never observed in the present patient cohort. 

Phrase: "Proteinuria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033687:Proteinuria [Finding]
  1000   C1962972:Proteinuria [Finding]

Phrase: "or"

Phrase: "renal failure without prior persistent MA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0035078:Renal Failure [Disease or Syndrome]
   790   C1963154:Renal failure [Finding]
   753   C0022646:Renal [Body Part, Organ, or Organ Component]
   753   C0231174:Failure [Functional Concept]
   753   C0680095:failure [Individual Behavior]

Phrase: "were"

Phrase: "never"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003901:Never [Temporal Concept]

Phrase: "observed in the present patient cohort."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0030705:*^patient [Patient or Disabled Group]
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]
   753   C0599755:Cohort [Population Group]
   753   C1441672:Observed [Functional Concept]
Processing 00000000.tx.14: Histopathological evaluation did not reveal glomerular lesions other than amyloid deposits to explain abnormal urinary albumin excretion. 

Phrase: "Histopathological evaluation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220825:Evaluation [Functional Concept]
   861   C1261322:Evaluation [Health Care Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "glomerular lesions other than amyloid"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0221198:lesions [Finding]
   726 E C1546698:Lesion [Intellectual Product]

Phrase: "deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposit [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explain"

Phrase: "abnormal urinary albumin excretion."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0042027:Urinary [Body Part, Organ, or Organ Component]
   812   C0221102:Excretion [Physiologic Function]
   812   C0504085:Excretion [Body Substance]
   812   C1524119:urinary [Qualitative Concept]
   812   C2699704:EXCRETION [Regulation or Law]
Processing 00000000.tx.15: The amount of mesangial and vascular-pole amyloid deposits was correlated with the degree of albuminuria. 

Phrase: "The amount of mesangial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "vascular-pole amyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2936349:Amyloid Deposits [Acquired Abnormality]
   812   C0333562:Deposits [Functional Concept]

Phrase: "was"

Phrase: "correlated with the degree of albuminuria."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0001925:Albuminuria [Finding]
   753   C0441889:Degree [Qualitative Concept]
   753   C0449286:Degree [Quantitative Concept]
   753   C0542560:Degree [Intellectual Product]
   753   C1561545:degree [Quantitative Concept]
   753   C1707520:Correlated [Qualitative Concept]
   753   C2348088:Degree [Quantitative Concept]
Processing 00000000.tx.16: Conclusions.

Phrase: "Conclusions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusions [Idea or Concept]
Processing 00000000.tx.17: Microalbuminuria represents the first stage of clinical TTR amyloid nephropathy and is premonitory of neuropathy. 

Phrase: "Microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the first stage of clinical TTR amyloid nephropathy"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0441766:First stage [Intellectual Product]
   767   C0205563:Clinical stage [Temporal Concept]
   744   C0205390:Stage [Temporal Concept]
   744   C0205435:First [Quantitative Concept]
   744   C1279901:First [Qualitative Concept]
   744   C1300072:Stage [Clinical Attribute]
   744   C1306673:Stage [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "premonitory of neuropathy."
Processing 00000000.tx.18: Its presence identifies a subgroup of patients who are more prone to develop overt nephropathy. 

Phrase: "Its presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "identifies"

Phrase: "a subgroup of patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1079230:subgroup [Virus]
   770   C1515021:Subgroup [Classification]

Phrase: "who"

Phrase: "are"

Phrase: "more prone to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033422:Prone [Spatial Concept]
   827   C0205172:More [Functional Concept]

Phrase: "develop"

Phrase: "overt nephropathy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022658:Nephropathy [Disease or Syndrome]
Processing 00000000.tx.19: Screening of MA may be important to assess disease onset and to recommend liver transplantation in individuals at risk. 

Phrase: "Screening of MA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0220908:Screening [Health Care Activity]
   790   C0220909:screening [Functional Concept]
   790   C1698960:screening [Intellectual Product]
   790   C1710031:Screening [Diagnostic Procedure]
   790   C1710477:SCREENING [Research Activity]

Phrase: "may"

Phrase: "be"

Phrase: "important to"

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "disease onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0277793:disease onset [Temporal Concept]
   861   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "recommend"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034866:recommend [Idea or Concept]

Phrase: "liver transplantation in individuals"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0023911:Liver Transplantation [Therapeutic or Preventive Procedure]
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   770   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   770   C0040733:transplantation [Functional Concept]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "at risk."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1444641:At risk [Qualitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C1516077:At [Spatial Concept]
Processing 00000000.tx.20: Keywords: amyloidosis; 

Phrase: "Keywords"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708608:Keyword [Intellectual Product]

Phrase: ":"

Phrase: "amyloidosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002726:Amyloidosis [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.21: glomerular; 

Phrase: "glomerular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022663:Glomerular [Body Part, Organ, or Organ Component]
  1000   C0268731:GLOMERULAR [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.22: kidney; 

Phrase: "kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.23: microalbuminuria; 

Phrase: "microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.24: proteinuria; 

Phrase: "proteinuria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033687:Proteinuria [Finding]
  1000   C1962972:Proteinuria [Finding]

Phrase: ";"
Processing 00000000.tx.25: transthyretin  Introduction Top Abstract Introduction Subjects and methods Results Discussion References  Familial amyloidoses are genetic disorders often caused by mutations in the transthyretin (TTR) gene [1]. 

Phrase: "transthyretin  Introduction Top Abstract Introduction Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   766   C0681850:Subject [Group]
   766   C1550501:{Subject} [Idea or Concept]
   766   C1706203:Subject [Idea or Concept]
   766   C2349001:Subject [Human]
   766   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Familial amyloidoses"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0740340:Familial Amyloidoses [Disease or Syndrome]
   861   C0002726:Amyloidoses [Disease or Syndrome]
   861   C0015576:familial [Family Group]
   861   C0241888:Familial [Functional Concept]
   789 E C1704727:Family [Conceptual Entity]

Phrase: "are"

Phrase: "genetic disorders often"
Meta Candidates (Total=21; Excluded=16; Pruned=0; Remaining=5)
   901   C0019247:Genetic Disorders [Disease or Syndrome]
   901   C2924406:Genetic disorders [Laboratory Procedure]
   873 E C0242354:birth disorders [Congenital Abnormality,Disease or Syndrome]
   859 E C0178829:Genital Disorders [Disease or Syndrome]
   827   C0012634:Disorders [Disease or Syndrome]
   827   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   827   C0314603:Genetic [Functional Concept]
   771 E C0005615:Birth [Organism Function]
   771 E C0035150:Reproduction [Organism Function]
   771 E C0079946:origin [Classification]
   771 E C0439659:Origin [Temporal Concept]
   771 E C1550512:origin [Intellectual Product]
   771 E C1550722:birth [Idea or Concept]
   771 E C3245487:birth [Intellectual Product]
   743 E C0454729:Natal [Geographic Area]
   743 E C0559522:Genital [Body System]
   743 E C1546649:Genital [Intellectual Product]
   743 E C1550642:Genital [Body Substance]
   734 E C0205313:Original [Idea or Concept]
   734 E C2347409:Original [Occupational Activity]
   716 E C0598240:originality [Mental Process]

Phrase: "caused by mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0026882:Mutations [Genetic Function]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the transthyretin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032923:Transthyretin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1421224:TRANSTHYRETIN [Gene or Genome]

Phrase: "(TTR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032923:Transthyretin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1421224:TRANSTHYRETIN [Gene or Genome]

Phrase: ")"

Phrase: "gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "[1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "]."
Processing 00000000.tx.26: The majority of TTR mutations are associated with amyloid neuropathy, cardiomyopathy, or nephropathy. 

Phrase: "The majority of TTR mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "are"

Phrase: "associated with amyloid neuropathy,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0206247:Amyloid neuropathy [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0442874:Neuropathy [Disease or Syndrome]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "cardiomyopathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878544:Cardiomyopathy [Disease or Syndrome]

Phrase: "or"

Phrase: "nephropathy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022658:Nephropathy [Disease or Syndrome]
Processing 00000000.tx.27: To date more than 60 TTR amyloidogenic mutations have been found, but TTR Val30Met (familial amyloid polyneuropathy type I, FAP) is by far the most frequent [2]. 

Phrase: "To date more"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011008:Date [Temporal Concept]
   861   C2348077:Date [Food]

Phrase: "than 60 TTR amyloidogenic mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: ","

Phrase: "but"

Phrase: "TTR Val30Met"

Phrase: "(familial amyloid polyneuropathy type I,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0268384:Amyloid polyneuropathy type I [Disease or Syndrome]
   840   C0441729:Type I [Classification]
   804   C0021966:I- [Inorganic Chemical]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   717   C0206245:Familial amyloid polyneuropathy [Disease or Syndrome]
   717   C2751492:AMYLOID POLYNEUROPATHY, FAMILIAL [Disease or Syndrome]

Phrase: "FAP"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0206245:Familial amyloid polyneuropathy [Disease or Syndrome]
  1000   C2751492:AMYLOID POLYNEUROPATHY, FAMILIAL [Disease or Syndrome]
   913   C0751448:Polyneuropathy, Familial [Disease or Syndrome]
   901   C0206247:Amyloid polyneuropathy [Disease or Syndrome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0015576:familial [Family Group]
   827   C0152025:Polyneuropathy [Disease or Syndrome]
   827   C0241888:Familial [Functional Concept]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   755 E C1704727:Family [Conceptual Entity]

Phrase: ")"

Phrase: "is by far"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205108:far [Spatial Concept]

Phrase: "the most frequent"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0332183:Frequent [Temporal Concept]
   789 E C0376249:frequency [Quantitative Concept]
   789 E C0439603:Frequencies [Temporal Concept]
   789 E C0871396:Frequency [Quantitative Concept]
   789 E C1561548:Frequency [Qualitative Concept]
   789 E C1705502:Frequency [Quantitative Concept]

Phrase: "[2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "]."
Processing 00000000.tx.28: The TTR Val30Met mutation has a worldwide distribution, and Portugal is the main geographic focus of this disease. 

Phrase: "The TTR Val30Met mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "has"

Phrase: "a worldwide distribution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "Portugal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032729:Portugal [Geographic Area]

Phrase: "is"

Phrase: "the main geographic focus of this disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205234:Focus [Spatial Concept]
   748   C1285542:focus [Functional Concept]
Processing 00000000.tx.29: Hereditary forms of amyloidosis involving the kidney were also related to mutations of apolipoprotein A-I and A-II [3,4], fibrinogen [5], lysozyme [6], and gelsolin [7] genes. 

Phrase: "Hereditary forms of amyloidosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "the kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "were"

Phrase: "also"

Phrase: "related to mutations of apolipoprotein A-I"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   814   C0085201:Apolipoprotein A-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0003592:Apolipoprotein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0021966:I- [Inorganic Chemical]
   748   C0026882:Mutations [Genetic Function]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   714 E C0163712:Relate [Organic Chemical]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "A-II"

Phrase: "[3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: "],"

Phrase: "fibrinogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016006:Fibrinogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1167394:fibrinogen [Cell Component]
  1000   C2587184:FIBRINOGEN [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "[5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "],"

Phrase: "lysozyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026794:Lysosyme [Enzyme,Pharmacologic Substance]
  1000   C1416945:LYSOZYME [Gene or Genome]
  1000   C3541379:lysozyme [Enzyme,Pharmacologic Substance]

Phrase: "[6"

Phrase: "],"

Phrase: "and"

Phrase: "gelsolin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0061187:Gelsolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415323:GELSOLIN [Gene or Genome]

Phrase: "[7"

Phrase: "] genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.30: Familial Mediterranean fever (FMF), and MuckleWells syndrome are the two hereditary varieties of AA amyloidosis, and in both, proteinuria and renal failure may complicate the clinical course [8,9]. 

Phrase: "Familial Mediterranean fever (FMF),"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0031069:Familial Mediterranean Fever [Disease or Syndrome]
   901   C0006309:Mediterranean fever [Disease or Syndrome]
   901   C1417104:Mediterranean fever [Gene or Genome]
   827   C0015576:familial [Family Group]
   827   C0015967:Fever [Finding]
   827   C0240321:Mediterranean [Population Group]
   827   C0241888:Familial [Functional Concept]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "and"

Phrase: "MuckleWells syndrome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039082:Syndrome [Disease or Syndrome]

Phrase: "are"

Phrase: "the two hereditary varieties of AA amyloidosis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1883525:Variety [Conceptual Entity]
   714   C2346866:Variety [Conceptual Entity]

Phrase: "and in both,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "proteinuria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033687:Proteinuria [Finding]
  1000   C1962972:Proteinuria [Finding]

Phrase: "and"

Phrase: "renal failure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035078:Renal Failure [Disease or Syndrome]
  1000   C1963154:Renal failure [Finding]
   861   C0022646:Renal [Body Part, Organ, or Organ Component]
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "may"

Phrase: "complicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231242:complicate [Functional Concept]

Phrase: "the clinical course"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449259:Clinical course [Temporal Concept]
   861   C0205210:Clinical [Qualitative Concept]
   861   C0750729:Course [Temporal Concept]

Phrase: "[8,"

Phrase: "9"

Phrase: "]."
Processing 00000000.tx.31: All are inherited in an autosomal dominant mode, except for FMF, which is transmitted as an autosomal recessive trait. 

Phrase: "All"

Phrase: "are"

Phrase: "inherited in an autosomal dominant mode,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0443147:Autosomal dominant [Intellectual Product]
   753   C0439660:Inherited [Functional Concept]
   753   C0596142:autosomal [Cell Component]
   753   C1513371:Mode [Functional Concept]
   753   C1527180:Dominant [Functional Concept]
   753   C1705738:Mode [Quantitative Concept]
   753   C2347637:Mode [Quantitative Concept]
   753   C2348146:Mode [Quantitative Concept]

Phrase: "except for FMF,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0031069:Familial Mediterranean Fever [Disease or Syndrome]
   901   C0006309:Mediterranean fever [Disease or Syndrome]
   901   C1417104:Mediterranean fever [Gene or Genome]
   827   C0015576:familial [Family Group]
   827   C0015967:Fever [Finding]
   827   C0240321:Mediterranean [Population Group]
   827   C0241888:Familial [Functional Concept]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "which"

Phrase: "is"

Phrase: "transmitted as an autosomal recessive trait."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0178492:autosomal recessive trait [Organism Attribute]
   790   C0441748:Autosomal recessive [Intellectual Product]
   753   C0242781:Transmitted [Pathologic Function]
   753   C0332289:transmitted [Functional Concept]
   753   C0596142:autosomal [Cell Component]
   753   C0599883:Trait [Organism Attribute]
   753   C1521797:Transmitted [Natural Phenomenon or Process]
Processing 00000000.tx.32: An autosomal dominant periodic fever occasionally associated with AA amyloidosis was also reported in families of European origin, revealing missense mutations in the gene encoding the tumour necrosis factor receptor [10,11]. 

Phrase: "An autosomal dominant periodic fever occasionally"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   840   C0015974:Periodic fever [Disease or Syndrome]
   804   C0015967:Fever [Finding]
   804   C0332182:Periodic [Temporal Concept]
   804   C1706381:PERIODIC [Intellectual Product]
   733 E C0031084:Periodicities [Temporal Concept]
   733 E C0439531:/period [Temporal Concept]
   733 E C1948053:Period [Temporal Concept]

Phrase: "associated with AA amyloidosis"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0221014:aa amyloidosis [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C3536715:AA amyloidosis [Disease or Syndrome]
   770   C0002726:Amyloidosis [Disease or Syndrome]
   770   C1235746:Aa [Plant]
   770   C1882141:aa [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "was"

Phrase: "also"

Phrase: "reported in families of European origin,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   820   C0870545:family of origin [Family Group]
           family origins
   790   C0425355:European origin [Finding]
   753   C0015576:Families [Family Group]
   753   C0079946:origin [Classification]
   753   C0239307:European [Population Group]
   753   C0439659:Origin [Temporal Concept]
   753   C0684224:Reported [Intellectual Product]
   753   C0700287:Reported [Health Care Activity]
   753   C1535514:European [Population Group]
   753   C1550512:origin [Intellectual Product]
   753   C1704727:Family [Conceptual Entity]
   753   C3496591:Reported [Clinical Attribute]
   731   C2919603:Original report [Intellectual Product]
   719 E C3273238:Report [Intellectual Product]

Phrase: "revealing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:revealing [Qualitative Concept]

Phrase: "missense mutations in the gene"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0599155:Mutations, Missense [Genetic Function]
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the tumour necrosis factor receptor"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0077503:Tumor Necrosis Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   923   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C1323304:tumor necrosis factor [Molecular Function]
   923   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0333516:Tumor necrosis [Neoplastic Process]
   812   C0027540:Necrosis [Organ or Tissue Function]
   812   C0027651:Tumor [Neoplastic Process]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1334928:Necrosis [Finding]
   812   C1521761:Factor [Functional Concept]
   812   C1578706:Tumor [Intellectual Product]
   812   C2827422:Factor [Conceptual Entity]
   812   C3273930:Tumor [Finding]

Phrase: "[10,"

Phrase: "11"

Phrase: "]."
Processing 00000000.tx.33: The pre-clinical stage of amyloid-associated nephropathy can be detected only by histological examination. 

Phrase: "The pre-clinical stage of amyloid-associated nephropathy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205563:Clinical stage [Temporal Concept]
   744   C0205390:Stage [Temporal Concept]
   744   C1300072:Stage [Clinical Attribute]
   744   C1306673:Stage [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "only by histological examination."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0019637:histologic examination [Laboratory Procedure]
   770   C0205171:Only [Quantitative Concept]
   770   C0205462:Histological [Functional Concept]
   770   C1720467:Only [Intellectual Product]
Processing 00000000.tx.34: The number of patients at this stage is unknown, as repeated urinalysis showed no abnormalities in biopsy-proven renal amyloidosis [8,12]. 

Phrase: "The number of patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   909   C2360800:Number of patients [Finding]
   802   C1830427:Patient number [Intellectual Product]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "at this stage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205390:Stage [Temporal Concept]
  1000   C1300072:Stage [Clinical Attribute]
  1000   C1306673:Stage [Qualitative Concept]

Phrase: "is"

Phrase: "unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "as"

Phrase: "repeated urinalysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042014:Urinalysis [Laboratory Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no abnormalities in biopsy-proven renal amyloidosis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0000768:Abnormalities [Congenital Abnormality]
   748   C0000769:abnormalities [Functional Concept]
   732   C0853712:abnormal biopsy [Finding]
   714 E C1704258:Abnormality [Finding]

Phrase: "[8,"

Phrase: "12"

Phrase: "]."
Processing 00000000.tx.35: Early detection of organ dysfunction caused by amyloid deposits has particular emphasis in TTR-related amyloidosis (ATTR), as it may determine prognosis and allocation in liver transplant programmes, which is the specific treatment for this disease [13]. 

Phrase: "Early detection of organ dysfunction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0596473:Early Detection [Diagnostic Procedure]
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "caused by amyloid deposits"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C2936349:Amyloid Deposits [Acquired Abnormality]
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0333562:Deposits [Functional Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "has"

Phrase: "particular emphasis in TTR-related amyloidosis"

Phrase: "(ATTR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032923:ATTR [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "it"

Phrase: "may"

Phrase: "determine"

Phrase: "prognosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033325:Prognosis [Health Care Activity]

Phrase: "and"

Phrase: "allocation in liver transplant programmes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1706778:Allocation [Activity]

Phrase: "which"

Phrase: "is"

Phrase: "the specific treatment for this disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C0205369:Specific [Qualitative Concept]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1552740:specific [Intellectual Product]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "[13"

Phrase: "]."
Processing 00000000.tx.36: FAP usually manifests as a sensorimotor neuropathy with autonomic dysfunction. 

Phrase: "FAP usually"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   923   C0206245:Familial amyloid polyneuropathy [Disease or Syndrome]
   923   C2751492:AMYLOID POLYNEUROPATHY, FAMILIAL [Disease or Syndrome]
   875   C0751448:Polyneuropathy, Familial [Disease or Syndrome]
   861   C0206247:Amyloid polyneuropathy [Disease or Syndrome]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0015576:familial [Family Group]
   812   C0152025:Polyneuropathy [Disease or Syndrome]
   812   C0241888:Familial [Functional Concept]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741 E C1704727:Family [Conceptual Entity]

Phrase: "manifests as a sensorimotor neuropathy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C3280431:Sensorimotor neuropathy [Finding]
   760   C0205319:Manifest [Functional Concept]
   760   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "with autonomic dysfunction."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0741307:Autonomic dysfunction [Pathologic Function]
   861   C0004388:Autonomic [Body System]
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.37: Life-span of this disease, before liver transplantation was accepted as a treatment, was on average 11 years. 

Phrase: "Life-span of this disease,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0870809:life span [Group Attribute]
   760   C0376558:Life [Idea or Concept]
   760   C1711300:Span [Conceptual Entity]
   760   C2700613:Span [Quantitative Concept]

Phrase: "before"

Phrase: "liver transplantation"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0023911:Liver Transplantation [Therapeutic or Preventive Procedure]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   861   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   861   C0040733:transplantation [Functional Concept]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "was"

Phrase: "accepted as a treatment,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1272684:Accepted [Qualitative Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1548435:Accepted [Idea or Concept]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737 E C1548601:Accept [Idea or Concept]

Phrase: "was on average 11 years."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439234:years [Temporal Concept]
   760   C1421478:WAS [Gene or Genome]
   760   C1510992:Average [Quantitative Concept]
   760   C2825518:AVERAGE [Quantitative Concept]
   726 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.38: Renal features of amyloid glomerular involvement can affect one-third of ATTR Val30Met patients [14]. 

Phrase: "Renal features of amyloid glomerular involvement"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   719   C1521970:Feature [Qualitative Concept]
   719   C1706388:Feature [Conceptual Entity]
   719   C2346469:Feature [Qualitative Concept]
   719   C2348519:Feature [Qualitative Concept]

Phrase: "can"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "one-third of ATTR Val30Met patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0032923:ATTR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205437:Third [Quantitative Concept]
   753   C0205447:One [Quantitative Concept]

Phrase: "[14"

Phrase: "]."
Processing 00000000.tx.39: Nephropathy occurs commonly with progression of the neurological disease, but in some instances may be present from the onset [15]. 

Phrase: "Nephropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022658:Nephropathy [Disease or Syndrome]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "commonly with progression of the neurological disease,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0027765:neurological disease [Disease or Syndrome]
   774   C0242656:Disease Progression [Pathologic Function]
           progression
   774   C1947900:Disease progression NOS [Finding]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0205494:Neurological [Qualitative Concept]
   748   C0449258:Progression [Functional Concept]
   748   C2707261:Neurological [Clinical Attribute]

Phrase: "but in some instances"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0233535:but [Mental or Behavioral Dysfunction]
   737   C1550608:Instance [Idea or Concept]

Phrase: "may"

Phrase: "be"

Phrase: "present from the onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "[15"

Phrase: "]."
Processing 00000000.tx.40: The aim of this study was to assess the value of microalbuminuria as a predictor of neuropathy and nephropathy in ATTR amyloidosis. 

Phrase: "The aim of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1947946:Aim [Idea or Concept]
   760   C2948600:Aim [Pharmacologic Substance]
   760   C3540471:AIM [Gene or Genome]
   760   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the value of microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1522609:Value [Quantitative Concept]

Phrase: "as a predictor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2698872:Predictor [Idea or Concept]

Phrase: "of neuropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "and"

Phrase: "nephropathy in ATTR amyloidosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0268382:Nephropathic amyloidosis [Disease or Syndrome]
   770   C0022658:Nephropathy [Disease or Syndrome]
Processing 00000000.tx.41: In addition, we explored whether different levels of urinary albumin excretion may reflect differences in glomerular amyloid deposition, establishing a correlation of microalbuminuria with pathological findings. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "explored"

Phrase: "whether"

Phrase: "different levels of urinary albumin excretion"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   783   C0243173:urinary levels [Functional Concept]
   783   C0428519:albumin levels [Laboratory or Test Result]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "differences in glomerular amyloid deposition,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "establishing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establishing [Qualitative Concept]

Phrase: "a correlation of microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707520:Correlation [Qualitative Concept]

Phrase: "with pathological findings."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   950   C1317598:Pathologic findings [Finding]
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]
Processing 00000000.tx.42: We excluded confounding factors in the interpretation of microalbuminuria, such as high blood pressure, diabetes, and obesity.  

Phrase: "We"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "confounding factors in the interpretation of microalbuminuria,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1521761:Factor [Functional Concept]
   714   C2827422:Factor [Conceptual Entity]

Phrase: "such as high blood pressure,"
Meta Candidates (Total=21; Excluded=7; Pruned=0; Remaining=14)
  1000   C0020538:Blood Pressure, High [Disease or Syndrome]
  1000   C2926615:High blood pressure [Clinical Attribute]
   901   C0005823:Blood Pressure [Organism Function]
   901   C1271104:Blood Pressure [Finding]
   901   C1272641:Blood pressure [Finding]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0033095:Pressure [Phenomenon or Process]
   827   C0205250:High [Qualitative Concept]
   827   C0229664:Blood [Body Substance]
   827   C0460139:Pressure [Finding]
   827   C1299351:High [Qualitative Concept]
   827   C1306345:Pressure [Functional Concept]
   827   C2700149:HIGH [Intellectual Product]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "obesity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]
Processing 00000000.tx.43: Subjects and methods Top Abstract Introduction Subjects and methods Results Discussion References  Patients Asymptomatic gene carriers and patients who had already developed neuropathy, all with TTR Val30Met mutation, were recruited from the registries of Centro de Estudos de Paramiloidose (CEP), during the period 1993-1999, and were prospectively followed. 

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "methods Top Abstract Introduction Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   771   C0681850:Subject [Group]
   771   C1550501:{Subject} [Idea or Concept]
   771   C1706203:Subject [Idea or Concept]
   771   C2349001:Subject [Human]
   771   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Patients Asymptomatic gene carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0007294:carriers [Finding]
   779 E C0560175:Carrier [Finding]
   779 E C1706209:Carrier [Medical Device]
   779 E C3273162:Carrier [Intellectual Product]

Phrase: "and"

Phrase: "patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "who"

Phrase: "had"

Phrase: "already developed neuropathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "all with TTR Val30Met mutation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0026882:Mutation [Genetic Function]
   760   C0032923:Transthyretin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0444868:All [Quantitative Concept]
   760   C1421224:TRANSTHYRETIN [Gene or Genome]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]
   760   C3539085:All [Idea or Concept]

Phrase: "were"

Phrase: "recruited from the registries of Centro de Estudos de Paramiloidose (CEP),"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   739   C0011198:DE [Geographic Area]
   739   C0017480:DE [Geographic Area]
   739   C0034975:Registries [Intellectual Product]
   739   C3245515:registries [Intellectual Product]
   739   C3541240:DE [Idea or Concept]

Phrase: "during the period 1993-1999,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   755 E C0332182:Periodic [Temporal Concept]
   755 E C1706381:PERIODIC [Intellectual Product]
   727 E C0031084:Periodicities [Temporal Concept]

Phrase: "and"

Phrase: "were"

Phrase: "prospectively"

Phrase: "followed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.44: As mean age-at-onset of neuropathy is 31.9 (17-78) years, in males, and 35.6 (2074) years, in females [14], we asked for the participation of asymptomatic subjects older than 25 years. 

Phrase: "As mean age-at-onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0206132:age onset [Quantitative Concept]
   812   C0001779:Age [Organism Attribute]
   812   C0332162:Onset [Qualitative Concept]

Phrase: "of neuropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "is"

Phrase: "31.9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "(17-78"

Phrase: ")"

Phrase: "years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439234:years [Temporal Concept]
   966 E C0439508:/year [Temporal Concept]

Phrase: "in males,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0024554:Males [Finding]
  1000   C0086582:Males [Population Group]
   966 E C1706180:Male [Qualitative Concept]
   966 E C1706428:Male [Qualitative Concept]
   966 E C1706429:Male [Organism Attribute]

Phrase: "and"

Phrase: "35.6"

Phrase: "(2074"

Phrase: ")"

Phrase: "years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439234:years [Temporal Concept]
   966 E C0439508:/year [Temporal Concept]

Phrase: "in females"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0015780:Females [Finding]
  1000   C0086287:Females [Population Group]
   966 E C0043210:female [Population Group]
   966 E C1705497:Female [Qualitative Concept]
   966 E C1705498:Female [Qualitative Concept]

Phrase: "[14"

Phrase: "],"

Phrase: "we"

Phrase: "asked for the participation of asymptomatic subjects"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0231221:Asymptomatic [Finding]
   748   C0679823:Participation [Functional Concept]
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]

Phrase: "older than 25 years."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0580836:Old [Temporal Concept]
Processing 00000000.tx.45: All subjects had a preliminary contact in which we explained our objectives, and consented to come regularly for a medical nephrological evaluation. 

Phrase: "All subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "had"

Phrase: "a preliminary contact in which"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332158:contact [Functional Concept]
   760   C0337611:Contact [Population Group]
   760   C1705415:Contact [Idea or Concept]

Phrase: "we"

Phrase: "explained"

Phrase: "our objectives,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018017:objectives [Intellectual Product]
   966 E C1571702:Objective [Qualitative Concept]

Phrase: "and"

Phrase: "consented"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C2711213:Consented [Qualitative Concept]
   966 E C1511481:Consent [Functional Concept]
   966 E C1554192:consent [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "come"

Phrase: "regularly for a medical nephrological evaluation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205476:Medical [Functional Concept]
   753   C0220825:Evaluation [Functional Concept]
   753   C1261322:Evaluation [Health Care Activity]
Processing 00000000.tx.46: Exclusion criteria were clinical or laboratory evidence of other disease (including hyperglycaemia, glycosuria, and obesity), and patients receiving angiotensin-converting-enzyme inhibitor and other medication affecting blood pressure. 

Phrase: "Exclusion criteria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0680251:Exclusion Criteria [Functional Concept]
   861   C0243161:criteria [Intellectual Product]

Phrase: "were"

Phrase: "clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "or"

Phrase: "laboratory evidence of other disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "hyperglycaemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "glycosuria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017979:Glycosuria [Finding]

Phrase: "and"

Phrase: "obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "receiving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514756:Receive [Qualitative Concept]

Phrase: "angiotensin-converting-enzyme inhibitor"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0003015:Angiotensin-converting enzyme inhibitor [Pharmacologic Substance]
  1000   C2757044:Angiotensin Converting Enzyme Inhibitor [Molecular Function]
  1000   C3536837:Angiotensin Converting Enzyme Inhibitor [Pharmacologic Substance]
   923   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   861   C0014432:Enzyme inhibitor [Pharmacologic Substance]
   861   C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C1999216:Inhibitor [Qualitative Concept]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "other medication affecting blood pressure."
Meta Candidates (Total=16; Excluded=7; Pruned=0; Remaining=9)
   861   C0005823:Blood Pressure [Organism Function]
   861   C1271104:Blood Pressure [Finding]
   861   C1272641:Blood pressure [Finding]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0033095:Pressure [Phenomenon or Process]
   812   C0229664:Blood [Body Substance]
   812   C0460139:Pressure [Finding]
   812   C1306345:Pressure [Functional Concept]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.47: We registered symptoms, age at onset, neurological examination, and electrocardiogram disturbances. 

Phrase: "We"

Phrase: "registered"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514821:Registered [Health Care Activity]
  1000   C1578536:Registered [Finding]

Phrase: "symptoms,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0683368:symptoms [Functional Concept]
  1000   C1457887:Symptoms [Sign or Symptom]

Phrase: "age at onset,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0206132:age onset [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]

Phrase: "neurological examination,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027853:Neurological Examination [Diagnostic Procedure]

Phrase: "and"

Phrase: "electrocardiogram disturbances."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2699787:Disturbance [Qualitative Concept]
Processing 00000000.tx.48: Patients were then asked to collect 24-h urine samples and to avoid exercise prior to the test. 

Phrase: "Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "asked"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "collect"

Phrase: "24-h urine samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C0444180:Urine sample [Body Substance]
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "avoid"

Phrase: "exercise prior to the test."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0015260:Exercise Test [Diagnostic Procedure]
   760   C0015259:Exercise [Daily or Recreational Activity]
   760   C1522704:Exercise [Therapeutic or Preventive Procedure]
Processing 00000000.tx.49: Urine collection was repeated if bacteriuria or pyuria were present. 

Phrase: "Urine collection"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0200354:Urine Collection [Laboratory Procedure]
   861   C1516698:Collection [Functional Concept]
   861   C1704814:Collection [Idea or Concept]
   789 E C1516695:Collected [Idea or Concept]

Phrase: "was"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "if"

Phrase: "bacteriuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004659:Bacteriuria [Disease or Syndrome]

Phrase: "or"

Phrase: "pyuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034359:Pyuria [Disease or Syndrome]

Phrase: "were"

Phrase: "present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.50: Twenty-nine asymptomatic and 38 patients with neuropathy participated in this study. 

Phrase: "Twenty-nine asymptomatic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0231221:Asymptomatic [Finding]

Phrase: "and"

Phrase: "38 patients with neuropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:Patients [Patient or Disabled Group]

Phrase: "participated in this study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
Processing 00000000.tx.51: Subjects were re-examined every year, if asymptomatic, or every 6 months if with overt disease. 

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "re-examined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332128:Examined [Finding]
   861   C2986904:RE [Idea or Concept]

Phrase: "every year,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439234:year [Temporal Concept]
  1000   C0439508:/year [Temporal Concept]

Phrase: "if"

Phrase: "asymptomatic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231221:Asymptomatic [Finding]

Phrase: "or"

Phrase: "every 6 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "if with overt disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0012634:Disease [Disease or Syndrome]
   770   C0750557:If [Qualitative Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.52: Blood-pressure measurement (in the morning, after rest, in the seated position, by mercury sphygmomanometer), 24-h urine collection, and blood sample analysis were repeated at each visit. 

Phrase: "Blood-pressure measurement"
Meta Candidates (Total=17; Excluded=7; Pruned=0; Remaining=10)
   901   C0005823:Blood Pressure [Organism Function]
   901   C1271104:Blood Pressure [Finding]
   901   C1272641:Blood pressure [Finding]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0033095:Pressure [Phenomenon or Process]
   827   C0229664:Blood [Body Substance]
   827   C0242485:Measurement [Functional Concept]
   827   C0460139:Pressure [Finding]
   827   C1306345:Pressure [Functional Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "("

Phrase: "in the morning,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332170:Morning [Temporal Concept]

Phrase: "after"

Phrase: "rest,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: "in the seated position,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "by mercury sphygmomanometer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183432:Mercury sphygmomanometer [Medical Device]
   861   C0183427:Sphygmomanometer [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "24-h urine collection,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0200354:Urine Collection [Laboratory Procedure]
   812   C1516698:Collection [Functional Concept]
   812   C1704814:Collection [Idea or Concept]
   741 E C1516695:Collected [Idea or Concept]

Phrase: "and"

Phrase: "blood sample analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1303103:Sample analysis [Laboratory Procedure]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0178913:Blood sample [Body Substance]

Phrase: "were"

Phrase: "repeated at each visit."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0205341:Repeated [Functional Concept]
   770   C0545082:Visit [Behavior]
   770   C1512346:visit [Health Care Activity]
   770   C2826704:VISIT [Intellectual Product]
   737 E C1547730:Repeat [Temporal Concept]
   737 E C1705914:Repeat [Conceptual Entity]
Processing 00000000.tx.53: Patients who developed any of the exclusion criteria mentioned above, or had a serum creatinine 1.3 mg/dl, or serum urea 50 mg/dl, or proteinuria in the first evaluation, were excluded from follow-up. 

Phrase: "Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "who"

Phrase: "developed"

Phrase: "any of the exclusion criteria"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0680251:Exclusion Criteria [Functional Concept]
           EXCLUSION
   760   C0243161:criteria [Intellectual Product]
   760   C1552551:Any [Qualitative Concept]
   760   C2828389:Exclusion [Activity]
   760   C3272371:ANY [Intellectual Product]

Phrase: "mentioned"

Phrase: "above,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "or"

Phrase: "had"

Phrase: "a serum creatinine 1.3 mg/dl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439269:mg dl [Quantitative Concept]
   799   C3642216:/dL [Quantitative Concept]

Phrase: "or"

Phrase: "serum urea 50 mg/dl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0439269:mg dl [Quantitative Concept]
   804   C3642216:/dL [Quantitative Concept]

Phrase: "or"

Phrase: "proteinuria in the first evaluation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033687:Proteinuria [Finding]
   760   C1962972:Proteinuria [Finding]

Phrase: "were"

Phrase: "excluded from follow-up."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0589120:Follow-up [Finding]
   833   C1522577:follow-up [Health Care Activity]
   833   C1704685:FOLLOW-UP [Intellectual Product]
   833   C3274571:FOLLOW-UP [Health Care Activity]
   770   C0332283:follow [Temporal Concept]
   770   C1554077:Excluded [Idea or Concept]
   770   C1719822:Follow [Intellectual Product]
   770   C2828389:Excluded [Activity]
   737 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.54: Kidney ultrasound was performed whenever an abnormal urine analysis was detected, excluding cortical scarring or obstructive uropathy. 

Phrase: "Kidney ultrasound"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0203408:kidney ultrasound [Diagnostic Procedure]
   861   C0041618:Ultrasound [Diagnostic Procedure]
   861   C0041621:ultrasound [Natural Phenomenon or Process]
   861   C0220934:ultrasound [Functional Concept]
   861   C1456803:Ultrasound [Natural Phenomenon or Process]
   861   C1875843:ULTRASOUND [Medical Device]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "whenever"

Phrase: "an abnormal urine analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0042014:urine analysis [Laboratory Procedure]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0235639:Abnormal urine [Finding]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "excluding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332196:Exclude [Functional Concept]
   966   C2828389:Exclude [Activity]

Phrase: "cortical scarring"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0008767:Scarring [Pathologic Function]
   861   C2004491:Scarring [Pathologic Function]
   827 E C0241158:scar [Finding]

Phrase: "or"

Phrase: "obstructive uropathy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178879:Obstructive uropathy [Disease or Syndrome]
   861   C0042075:UROPATHY [Disease or Syndrome]
   861   C0549186:Obstructive [Functional Concept]
Processing 00000000.tx.55: Our follow-up ended in December 2000 or when the patient underwent orthotopic liver transplantation. 

Phrase: "Our follow-up ended in December 2000"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C1272693:Ended [Qualitative Concept]
   748   C2746065:Ended [Temporal Concept]
   714 E C0444930:End [Spatial Concept]

Phrase: "or"

Phrase: "when"

Phrase: "the patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "underwent"

Phrase: "orthotopic liver transplantation."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0400447:Orthotopic Liver Transplantation [Therapeutic or Preventive Procedure]
   901   C0023911:Liver Transplantation [Therapeutic or Preventive Procedure]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   827   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   827   C0040733:transplantation [Functional Concept]
   827   C0574893:Orthotopic [Spatial Concept]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.56: If this was the case, kidney biopsies were performed as part of the pre-operative evaluation, after obtaining written informed consent. 

Phrase: "If"

Phrase: "this"

Phrase: "was"

Phrase: "the case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "kidney biopsies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0194073:Kidney biopsy [Diagnostic Procedure]
   861   C0005558:biopsies [Diagnostic Procedure]
   827 E C0220797:biopsy [Functional Concept]

Phrase: "were"

Phrase: "performed as part of the pre-operative evaluation,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   800   C1293091:Pre-operative evaluation [Diagnostic Procedure]
   770   C0445204:Pre-operative [Temporal Concept]
   770   C1292711:Part of [Spatial Concept]
   744   C0220825:Evaluation [Functional Concept]
   744   C0332152:Pre [Temporal Concept]
   744   C0449719:Part [Spatial Concept]
   744   C0740175:Pre [Qualitative Concept]
   744   C0884358:Performed [Functional Concept]
   744   C1261322:Evaluation [Health Care Activity]
   744   C1709471:Part [Quantitative Concept]
   744   C1882154:Operative [Temporal Concept]
   744   C2257086:PRE [Genetic Function]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "after"

Phrase: "obtaining"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   966   C1301820:Obtain [Functional Concept]
   966   C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "written informed consent."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0021430:Informed Consent [Regulation or Law]
   827   C1511481:Consent [Functional Concept]
   827   C1522154:Informed [Qualitative Concept]
   827   C1554192:consent [Idea or Concept]
   793 E C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   793 E C0700287:inform [Health Care Activity]
   793 E C1552002:inform [Idea or Concept]
Processing 00000000.tx.57: Assays DNA analysis by PCR amplification was used to detect the TTR Val30Met mutation in all subjects. 

Phrase: "Assays DNA analysis by PCR amplification"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0200898:DNA analysis [Laboratory Procedure]
   783   C0200931:PCR analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the TTR Val30Met mutation in all subjects."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.58: Urinary albumin excretion (UAE) was measured by immunoturbidimetric method (Roche Diagnostics), with a limit of detection of 0.6 mg/dl and an interassay variation of 4.3%. 

Phrase: "Urinary albumin excretion (UAE)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0042027:Urinary [Body Part, Organ, or Organ Component]
   827   C0221102:Excretion [Physiologic Function]
   827   C0504085:Excretion [Body Substance]
   827   C1524119:urinary [Qualitative Concept]
   827   C2699704:EXCRETION [Regulation or Law]

Phrase: "was"

Phrase: "measured by immunoturbidimetric method"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0025663:Method [Intellectual Product]
   770   C0444706:Measured [Qualitative Concept]
   770   C0449851:Method [Functional Concept]
   770   C0871511:METHOD [Intellectual Product]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "(Roche Diagnostics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011900:Diagnostic [Finding]
   827   C0348026:Diagnostic [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "with a limit"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]
   928 E C3542948:Limited [Intellectual Product]

Phrase: "of detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "of 0.6 mg/dl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439269:mg dl [Quantitative Concept]
   812   C3642216:/dL [Quantitative Concept]

Phrase: "and"

Phrase: "an interassay variation of 4.3%."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:Variation [Qualitative Concept]
Processing 00000000.tx.59: Microalbuminuria (MA) was defined as UAE 20 g/min and 200 g/min in two measurements with a week's interval. 

Phrase: "Microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "(MA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: ")"

Phrase: "was"

Phrase: "defined as UAE 20 g/min"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0560021:g/min [Quantitative Concept]
   744   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0042027:Urinary [Body Part, Organ, or Organ Component]
   744   C0221102:Excretion [Physiologic Function]
   744   C0439267:g% [Quantitative Concept]
   744   C0504085:Excretion [Body Substance]
   744   C0702093:/min [Temporal Concept]
   744   C1524119:urinary [Qualitative Concept]
   744   C1704788:Defined [Conceptual Entity]
   744   C2699704:EXCRETION [Regulation or Law]
   744   C3539106:Defined [Intellectual Product]

Phrase: "and"

Phrase: "200 g/min in two measurements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0560021:g/min [Quantitative Concept]
   753   C0702093:/min [Temporal Concept]

Phrase: "with a week's interval."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]
Processing 00000000.tx.60: Overt nephropathy was defined as UAE >200 g/min. 

Phrase: "Overt nephropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022658:Nephropathy [Disease or Syndrome]

Phrase: "was"

Phrase: "defined as UAE"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0042027:Urinary [Body Part, Organ, or Organ Component]
   760   C0221102:Excretion [Physiologic Function]
   760   C0504085:Excretion [Body Substance]
   760   C1524119:urinary [Qualitative Concept]
   760   C1704788:Defined [Conceptual Entity]
   760   C2699704:EXCRETION [Regulation or Law]
   760   C3539106:Defined [Intellectual Product]

Phrase: ">200 g/min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0560021:g/min [Quantitative Concept]
   827   C0702093:/min [Temporal Concept]
Processing 00000000.tx.61: Serum and urinary creatinine concentrations were measured by standard colorimetric methods. 

Phrase: "Serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "urinary creatinine concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   896   C0232827:Urinary concentration [Organ or Tissue Function]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "measured by standard colorimetric methods."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0444706:Measured [Qualitative Concept]
   760   C0449851:Methods [Functional Concept]
   760   C1442989:Standard [Qualitative Concept]
   760   C2828392:Standard [Intellectual Product]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.62: Creatinine clearance was used as an index of glomerular filtration rate. 

Phrase: "Creatinine clearance"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0812399:Creatinine clearance [Finding]
   861   C0010294:Creatinine [Biologically Active Substance,Organic Chemical]
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C1561535:Creatinine [Finding]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "used as an index of glomerular filtration rate."
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   800   C0017654:Glomerular Filtration Rate [Diagnostic Procedure]
   800   C1561549:Glomerular filtration rate [Finding]
   770   C0232809:Glomerular filtration [Organ or Tissue Function]
   750   C1524063:Use of [Functional Concept]
   744   C0016107:filtration [Laboratory Procedure]
   744   C0022663:Glomerular [Body Part, Organ, or Organ Component]
   744   C0268731:GLOMERULAR [Disease or Syndrome]
   744   C0871208:Rate [Activity]
   744   C0918012:Index [Intellectual Product]
   744   C1273517:used [Finding]
   744   C1521828:Rate [Quantitative Concept]
   744   C1552854:index [Idea or Concept]
   744   C1637833:% index [Quantitative Concept]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.63: We considered there to be renal failure when the creatinine clearance was <80 ml/min/1.73 m2. 

Phrase: "We"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "there to"

Phrase: "be"

Phrase: "renal failure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035078:Renal Failure [Disease or Syndrome]
  1000   C1963154:Renal failure [Finding]
   861   C0022646:Renal [Body Part, Organ, or Organ Component]
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "when"

Phrase: "the creatinine clearance"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0812399:Creatinine clearance [Finding]
   861   C0010294:Creatinine [Biologically Active Substance,Organic Chemical]
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C1561535:Creatinine [Finding]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "was <"

Phrase: "80 ml/min/1.73 m2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   876   C1532780:mL/m2 [Quantitative Concept]
   799   C0457242:m2 [Quantitative Concept]
Processing 00000000.tx.64: Each renal biopsy was fixed in formol for Congo-red staining, and frozen for indirect immunoperoxidase technique with anti-TTR monoclonal antibody [15,16]. 

Phrase: "Each renal biopsy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0194073:Renal biopsy [Diagnostic Procedure]
   861   C0005558:Biopsy [Diagnostic Procedure]
   861   C0220797:biopsy [Functional Concept]

Phrase: "was"

Phrase: "fixed in formol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0016584:Formol [Hazardous or Poisonous Substance,Organic Chemical]
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C2827483:Fixed [Body Substance]

Phrase: "for Congo-red staining,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009742:congo red staining [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Congo Red
  1000   C1293958:congo red staining [Laboratory Procedure]
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "frozen for indirect immunoperoxidase technique"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0021067:Technique, Immunoperoxidase [Laboratory Procedure]
           Immunoperoxidase
   797   C0203939:Indirect technique [Therapeutic or Preventive Procedure]
   781   C0016701:Freeze Technique [Natural Phenomenon or Process]
           Frozen
   760   C0439852:Indirect [Qualitative Concept]
   760   C0449851:Technique [Functional Concept]
   760   C0677542:Frozen [Functional Concept]

Phrase: "with anti-TTR monoclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0746619:monoclonal [Finding]

Phrase: "[15,"

Phrase: "16"

Phrase: "]."
Processing 00000000.tx.65: The presence and amount of amyloid, graded on a scale from - (absent) to +++ (more than 50% of the structure involved) was analysed in the glomerular structures by light microscopy, as described previously [15]. 

Phrase: "The presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "amount of amyloid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1265611:Amount [Quantitative Concept]

Phrase: "graded on a scale"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0175659:Scale [Medical Device]
   770   C0349674:Scale [Intellectual Product]
   770   C1947916:Scale [Activity]
   770   C3536777:Scale [Manufactured Object]
   737   C0441800:Grade [Classification]
   737   C0919553:Grade [Classification]
   737   C3244287:grade [Finding]

Phrase: "from -"

Phrase: "(absent"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332197:Absent [Quantitative Concept]
  1000   C2699517:ABSENT [Finding]
   928 E C0424530:Absences [Finding]
   928 E C1689985:Absence [Anatomical Abnormality]

Phrase: ")"

Phrase: "to +++ (more than 50% of the structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0678594:Structure [Spatial Concept]
   748   C1883351:To [Qualitative Concept]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: ")"

Phrase: "was"

Phrase: "analysed in the glomerular structures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0022663:Glomerular [Body Part, Organ, or Organ Component]
           Glomerulus structure
   760   C0268731:GLOMERULAR [Disease or Syndrome]
   760   C0678594:structures [Spatial Concept]

Phrase: "by light microscopy,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0430389:Light microscopy [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "[15"

Phrase: "]."
Processing 00000000.tx.66: Statistical analysis Comparisons between groups with nephropathy or ESRD and without nephropathy were performed with the chi-square statistic, in the case of categorical variables, and the Student t-test in the case of continuous variables; 

Phrase: "Statistical analysis Comparisons between groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1707455:Comparison [Activity]

Phrase: "with nephropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022658:Nephropathy [Disease or Syndrome]

Phrase: "or"

Phrase: "ESRD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022661:ESRD [Disease or Syndrome]
  1000   C0035078:ESRD [Disease or Syndrome]
  1000   C2316810:ESRD [Disease or Syndrome,Finding]

Phrase: "and without nephropathy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0022658:Nephropathy [Disease or Syndrome]
   790   C1515981:And [Idea or Concept]

Phrase: "were"

Phrase: "performed with the chi-square statistic,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C1552646:chi square [Quantitative Concept]
   753   C0205120:Square [Spatial Concept]
   753   C0884358:Performed [Functional Concept]
   753   C1552595:Square [Intellectual Product]
   753   C1720589:Chi [Intellectual Product]
   753   C2348149:Statistic [Quantitative Concept]
   753   C2828391:Statistic [Quantitative Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of categorical variables,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:variables [Qualitative Concept]

Phrase: "and"

Phrase: "the Student t-test in the case of continuous variables"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0022885:Test [Laboratory Procedure]
   739   C0038492:student [Professional or Occupational Group]
   739   C0039593:Test [Functional Concept]
   739   C0392366:test [Intellectual Product]
   739   C1551041:student [Idea or Concept]
   739   C1552573:student [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.67: relative risk (RR) to develop neuropathy was expressed with 95% confidence interval (CI). 

Phrase: "relative risk (RR) to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0242492:Relative Risk [Quantitative Concept]
   827   C0035647:Risk [Qualitative Concept]
   827   C0080103:Relative [Family Group]
   827   C0205345:Relative [Qualitative Concept]
   827   C1547039:*Relative [Quantitative Concept]

Phrase: "develop"

Phrase: "neuropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "was"

Phrase: "expressed with 95% confidence interval (CI)."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0009667:Confidence Interval [Quantitative Concept]
   760   C0237529:Confidence [Mental Process]
   760   C1272706:Interval [Temporal Concept]
   760   C1552654:Interval [Idea or Concept]
   760   C1552713:Interval [Intellectual Product]
   760   C1704725:Confidence [Qualitative Concept]
   760   C1704726:Confidence [Mental Process]
Processing 00000000.tx.68: Descriptive statistics were given as averageSD; 

Phrase: "Descriptive statistics"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0038215:Statistics [Occupation or Discipline]
   861   C0600673:Statistics [Intellectual Product]
   827 E C2348149:Statistic [Quantitative Concept]
   827 E C2828391:Statistic [Quantitative Concept]

Phrase: "were"

Phrase: "given as averageSD"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1442162:GIVEN [Conceptual Entity]
   790   C1550718:given [Idea or Concept]
   790   C3244317:given [Intellectual Product]
   756 E C1947971:Give [Functional Concept]

Phrase: ";"
Processing 00000000.tx.69: P<0.05 was regarded as statistically significant.  

Phrase: "P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "was"

Phrase: "regarded as statistically significant."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0237881:statistically significant [Quantitative Concept]
           significant
   770   C0038215:Statistically [Occupation or Discipline]
   770   C0750502:Significant [Idea or Concept]
   770   C1546944:Significant [Qualitative Concept]
   761 E C1709380:Statistical Significance [Quantitative Concept]
Processing 00000000.tx.70: Results Top Abstract Introduction Subjects and methods Results Discussion References  In the first evaluation, we studied 29 asymptomatic gene carriers (9 males/20 females), and 38 patients with neuropathy (16 males/22 females). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References  In the first evaluation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205435:First [Quantitative Concept]
   760   C0220825:Evaluation [Functional Concept]
   760   C1261322:Evaluation [Health Care Activity]
   760   C1279901:First [Qualitative Concept]
   760   C1514811:Reference [Idea or Concept]
   760   C1706462:Reference [Conceptual Entity]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "29 asymptomatic gene carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0007294:carriers [Finding]
   779 E C0560175:Carrier [Finding]
   779 E C1706209:Carrier [Medical Device]
   779 E C3273162:Carrier [Intellectual Product]

Phrase: "(9 males/20 females"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0015780:Females [Finding]
   812   C0086287:Females [Population Group]
   779 E C0043210:female [Population Group]
   779 E C1705497:Female [Qualitative Concept]
   779 E C1705498:Female [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "38 patients with neuropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:Patients [Patient or Disabled Group]

Phrase: "(16 males/22 females"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0015780:Females [Finding]
   812   C0086287:Females [Population Group]
   779 E C0043210:female [Population Group]
   779 E C1705497:Female [Qualitative Concept]
   779 E C1705498:Female [Qualitative Concept]
   708   C0450329:16/22 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.71: Overt nephropathy was diagnosed in one asymptomatic subject and three patients. 

Phrase: "Overt nephropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022658:Nephropathy [Disease or Syndrome]

Phrase: "was"

Phrase: "diagnosed in one asymptomatic subject"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0011900:Diagnosed [Finding]
   760   C0205447:One [Quantitative Concept]
   760   C0231221:Asymptomatic [Finding]
   760   C0681850:Subject [Group]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1706203:Subject [Idea or Concept]
   760   C2349001:Subject [Human]
   760   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "three patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.72: Nine subjects showed exclusion criteria for follow-up. 

Phrase: "Nine subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "exclusion criteria for follow-up."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0680251:Exclusion Criteria [Functional Concept]
   760   C0243161:criteria [Intellectual Product]
Processing 00000000.tx.73: Our analysis was thus based on 22 asymptomatic carriers (7 males/15 females), and 32 patients (14 males/18 females). 

Phrase: "Our analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "thus"

Phrase: "based on 22 asymptomatic carriers"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   760   C0007294:carriers [Finding]
   760   C0231221:Asymptomatic [Finding]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C0560175:Carrier [Finding]
   726 E C1706209:Carrier [Medical Device]
   726 E C1880279:Base [Biomedical or Dental Material]
   726 E C3273162:Carrier [Intellectual Product]

Phrase: "(7 males/15 females"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0015780:Females [Finding]
   812   C0086287:Females [Population Group]
   779 E C0043210:female [Population Group]
   779 E C1705497:Female [Qualitative Concept]
   779 E C1705498:Female [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "32 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "(14 males/18 females"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0015780:Females [Finding]
   812   C0086287:Females [Population Group]
   779 E C0043210:female [Population Group]
   779 E C1705497:Female [Qualitative Concept]
   779 E C1705498:Female [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.74: Microalbuminuria: prevalence and evolution to overt nephropathy Asymptomatic carriers Table 1 details clinical characteristics at first examination, and Figure 1 resumes the evolution during follow-up. 

Phrase: "Microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: ":"

Phrase: "prevalence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033105:Prevalence [Quantitative Concept]
  1000   C0220900:prevalence [Quantitative Concept]

Phrase: "and"

Phrase: "evolution to overt nephropathy Asymptomatic carriers Table 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0015219:Evolution [Genetic Function]

Phrase: "details"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1522508:Detail [Qualitative Concept]
  1000   C1561567:detail [Functional Concept]

Phrase: "clinical characteristics at first examination,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0683325:clinical characteristics [Clinical Attribute]
   760   C1521970:Characteristics [Qualitative Concept]

Phrase: "and"

Phrase: "Figure 1"

Phrase: "resumes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550028:Resume [Idea or Concept]
  1000   C1880201:Resume [Intellectual Product]
  1000   C3242342:resume [Functional Concept]

Phrase: "the evolution during follow-up."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0015219:Evolution [Genetic Function]
Processing 00000000.tx.75: Neuropathy developed, on average, 2.32.2 years after detection of microalbuminuria. 

Phrase: "Neuropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "developed"

Phrase: ","

Phrase: "on average,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510992:Average [Quantitative Concept]
  1000   C2825518:AVERAGE [Quantitative Concept]

Phrase: "2.32.2 years after detection of microalbuminuria."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0439234:years [Temporal Concept]
   711 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.76: One subject developed microalbuminuria (34.2 g/min) on the third and last year of follow-up, and was still asymptomatic. 

Phrase: "One subject developed microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "(34.2 g/min) on the third"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0560021:g/min [Quantitative Concept]
   748   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "last year of follow-up,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439234:year [Temporal Concept]
   760   C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "was"

Phrase: "still asymptomatic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0231221:Asymptomatic [Finding]
Processing 00000000.tx.77: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.78: Clinical characteristics of asymptomatic carriers and patients with neuropathy at first urine collection  View larger version (11K): [in this window] [in a new window]  Fig. 

Phrase: "Clinical characteristics of asymptomatic carriers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0683325:clinical characteristics [Clinical Attribute]
   760   C1521970:Characteristics [Qualitative Concept]

Phrase: "and"

Phrase: "patients with neuropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "at first urine collection"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0200354:Urine Collection [Laboratory Procedure]
   827   C1516698:Collection [Functional Concept]
   827   C1704814:Collection [Idea or Concept]
   755 E C1516695:Collected [Idea or Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(11K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.79: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.80: Asymptomatic gene carriers: evolution to neuropathy and nephropathy during a mean follow-up of 6.11.3 years. 

Phrase: "Asymptomatic gene carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0007294:carriers [Finding]
   793 E C0560175:Carrier [Finding]
   793 E C1706209:Carrier [Medical Device]
   793 E C3273162:Carrier [Intellectual Product]

Phrase: ":"

Phrase: "evolution to neuropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0015219:Evolution [Genetic Function]

Phrase: "and"

Phrase: "nephropathy during a mean"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0022658:Nephropathy [Disease or Syndrome]

Phrase: "follow-up of 6.11.3 years."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0589120:Follow-up [Finding]
   778   C1522577:follow-up [Health Care Activity]
   778   C1704685:FOLLOW-UP [Intellectual Product]
   778   C3274571:FOLLOW-UP [Health Care Activity]
   748   C0332283:follow [Temporal Concept]
   748   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.81: Numbers of subjects with each clinical condition.  

Phrase: "Numbers of subjects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0237753:*Number [Quantitative Concept]
   790   C0449788:Number [Quantitative Concept]

Phrase: "with each clinical condition."
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C0012634:condition [Disease or Syndrome]
   861   C0205210:Clinical [Qualitative Concept]
   861   C0348080:Condition [Qualitative Concept]
   861   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   789 E C0009647:Conditioned [Mental Process]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.82: Development of neuropathy in asymptomatic gene carriers with microalbuminuria was significantly more frequent than in those with normal urinary albumin excretion (7/8 vs 6/14; P=0.04). 

Phrase: "Development of neuropathy"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0243107:development [Physiologic Function]
   790   C0678723:Development [Organism Function]
   790   C1527148:Development [Functional Concept]
   718 E C0458003:Developmental [Qualitative Concept]

Phrase: "in asymptomatic gene carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0007294:carriers [Finding]
   793 E C0560175:Carrier [Finding]
   793 E C1706209:Carrier [Medical Device]
   793 E C3273162:Carrier [Intellectual Product]

Phrase: "with microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "was"

Phrase: "significantly more frequent than"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332183:Frequent [Temporal Concept]

Phrase: "in those with normal urinary albumin excretion"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   853   C0860865:normal albumin [Finding]
   804   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0042027:Urinary [Body Part, Organ, or Organ Component]
   804   C0221102:Excretion [Physiologic Function]
   804   C0504085:Excretion [Body Substance]
   804   C1524119:urinary [Qualitative Concept]
   804   C2699704:EXCRETION [Regulation or Law]

Phrase: "(7/8"

Phrase: "vs"

Phrase: "6/14"

Phrase: "; P=0.04"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.83: The relative risk for asymptomatic gene carriers with microalbuminuria developing neuropathy was 4.8 (95% CI, 0.7-32.9), meaning that among asymptomatic carriers, there was a 4.8-fold risk of becoming neuropathic, compared to subjects with normal urinary albumin excretion. 

Phrase: "The relative risk for asymptomatic gene carriers"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0242492:Relative Risk [Quantitative Concept]
   748   C0035647:Risk [Qualitative Concept]
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C1547039:*Relative [Quantitative Concept]

Phrase: "with microalbuminuria developing neuropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "was"

Phrase: "4.8"

Phrase: "(95% CI,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "0.7-32.9"

Phrase: ")"

Phrase: ","

Phrase: "meaning"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0876919:Meaning [Idea or Concept]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "that among asymptomatic carriers,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007294:carriers [Finding]
   770   C0231221:Asymptomatic [Finding]
   737 E C0560175:Carrier [Finding]
   737 E C1706209:Carrier [Medical Device]
   737 E C3273162:Carrier [Intellectual Product]

Phrase: "there"

Phrase: "was"

Phrase: "a 4.8-fold risk of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035647:Risk [Qualitative Concept]

Phrase: "becoming"

Phrase: "neuropathic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "compared to subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with normal urinary albumin excretion."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C0860865:normal albumin [Finding]
   812   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0042027:Urinary [Body Part, Organ, or Organ Component]
   812   C0221102:Excretion [Physiologic Function]
   812   C0504085:Excretion [Body Substance]
   812   C1524119:urinary [Qualitative Concept]
   812   C2699704:EXCRETION [Regulation or Law]
Processing 00000000.tx.84: When microalbuminuria preceded the onset of neurological symptoms, evolution to overt renal disease occurred in three of seven cases, and in all of them during the first year of neurological symptoms. 

Phrase: "When"

Phrase: "microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "preceded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332152:preceded [Temporal Concept]

Phrase: "the onset of neurological symptoms,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332162:Onset [Qualitative Concept]

Phrase: "evolution to overt renal disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0015219:Evolution [Genetic Function]

Phrase: "occurred in three of seven cases,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0205449:Three [Quantitative Concept]
   753   C0205453:Seven [Quantitative Concept]
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   753   C1709305:Occurred [Activity]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]
   719 E C2745955:OCCUR [Temporal Concept]

Phrase: "and in all of them"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1515981:And [Idea or Concept]

Phrase: "during the first year"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439234:year [Temporal Concept]
   861   C0439508:/year [Temporal Concept]

Phrase: "of neurological symptoms."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0235031:neurological symptoms [Sign or Symptom]
   861   C0683368:symptoms [Functional Concept]
   861   C1457887:Symptoms [Sign or Symptom]
Processing 00000000.tx.85: None of the cases starting neurological symptoms with normal urinary albumin excretion evolved to clinical nephropathy, after a period of 2-6 years of observation from the onset of neuropathy. 

Phrase: "None of the cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "starting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Start [Temporal Concept]

Phrase: "neurological symptoms with normal urinary albumin excretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0235031:neurological symptoms [Sign or Symptom]
   774   C0426359:Urinary symptoms [Sign or Symptom]
   748   C0683368:symptoms [Functional Concept]
   748   C1457887:Symptoms [Sign or Symptom]

Phrase: "evolved to clinical nephropathy,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0022658:Nephropathy [Disease or Syndrome]
   770   C0205210:Clinical [Qualitative Concept]
   770   C0332253:evolved [Functional Concept]

Phrase: "after"

Phrase: "a period of 2-6 years of observation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0567305:Observation of period [Finding]
   744   C0439531:/period [Temporal Concept]
   744   C1948053:Period [Temporal Concept]

Phrase: "from the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of neuropathy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442874:Neuropathy [Disease or Syndrome]
Processing 00000000.tx.86: No sex differences were registered respecting presence or development of microalbuminuria. 

Phrase: "No sex differences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0036866:Sex Differences [Organism Attribute]
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "registered"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514821:Registered [Health Care Activity]
  1000   C1578536:Registered [Finding]

Phrase: "respecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0679133:respect [Social Behavior]

Phrase: "presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "development of microalbuminuria."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0243107:development [Physiologic Function]
   790   C0678723:Development [Organism Function]
   790   C1527148:Development [Functional Concept]
   718 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.87: Patients with neuropathy Table 1 shows clinical characteristics of patients when the study began. 

Phrase: "Patients with neuropathy Table 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "clinical characteristics of patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0683325:clinical characteristics [Clinical Attribute]
   802   C0815172:patient characteristics [Clinical Attribute]
   770   C1521970:Characteristics [Qualitative Concept]

Phrase: "when"

Phrase: "the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "began."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]
Processing 00000000.tx.88: In 13 patients (4 males/9 females) microalbuminuria was detected at the beginning of the study, and in 11 (5 males/6 females) microalbuminuria developed subsequently, on average, after 3.21.7 years of follow-up. 

Phrase: "In 13 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "(4 males/9 females"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0015780:Females [Finding]
   812   C0086287:Females [Population Group]
   779 E C0043210:female [Population Group]
   779 E C1705497:Female [Qualitative Concept]
   779 E C1705498:Female [Qualitative Concept]

Phrase: ")"

Phrase: "microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "was"

Phrase: "detected at the beginning of the study,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0439659:Beginning [Temporal Concept]
   748   C0442726:Detected [Finding]
   748   C0557651:Study [Manufactured Object]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C2603343:Study [Research Activity]

Phrase: "and in 11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "(5 males/6 females"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0015780:Females [Finding]
   812   C0086287:Females [Population Group]
   779 E C0043210:female [Population Group]
   779 E C1705497:Female [Qualitative Concept]
   779 E C1705498:Female [Qualitative Concept]
   708   C0442749:5 6 [Finding]

Phrase: ")"

Phrase: "microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "developed"

Phrase: "subsequently,"

Phrase: "on average,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510992:Average [Quantitative Concept]
  1000   C2825518:AVERAGE [Quantitative Concept]

Phrase: "after"

Phrase: "3.21.7 years of follow-up."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0439234:years [Temporal Concept]
   714 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.89: Figure 2 summarizes the evolution of renal disease in neuropathic patients. 

Phrase: "Figure 2"

Phrase: "summarizes"

Phrase: "the evolution of renal disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0015219:Evolution [Genetic Function]

Phrase: "in neuropathic patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.90: Evolution to overt nephropathy occurred in 13 (3 males/9 females) of the 24 patients in whom microalbuminuria was detected; 

Phrase: "Evolution to overt nephropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015219:Evolution [Genetic Function]

Phrase: "occurred in 13"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1709305:Occurred [Activity]
   756 E C2745955:OCCUR [Temporal Concept]

Phrase: "(3 males/9 females"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0015780:Females [Finding]
   812   C0086287:Females [Population Group]
   779 E C0043210:female [Population Group]
   779 E C1705497:Female [Qualitative Concept]
   779 E C1705498:Female [Qualitative Concept]
   708   C0442760:3/9 [Finding]

Phrase: ")"

Phrase: "of the 24 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "in whom microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ";"
Processing 00000000.tx.91: conversely, renal disease was absent in the 10 subjects (5 males/5 females) maintaining normal urinary albumin excretion during the follow-up (P=0.006). 

Phrase: "conversely,"

Phrase: "renal disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0022658:Renal disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0022646:Renal [Body Part, Organ, or Organ Component]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "absent in the 10 subjects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:Absent [Quantitative Concept]
   760   C2699517:ABSENT [Finding]

Phrase: "(5 males/5 females"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0015780:Females [Finding]
   812   C0086287:Females [Population Group]
   779 E C0043210:female [Population Group]
   779 E C1705497:Female [Qualitative Concept]
   779 E C1705498:Female [Qualitative Concept]
   708   C0450380:5/5 [Quantitative Concept]

Phrase: ")"

Phrase: "maintaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0024501:Maintain [Activity]

Phrase: "normal urinary albumin excretion during the follow-up"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C0860865:albumin normal [Finding]
   744   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0042027:Urinary [Body Part, Organ, or Organ Component]
   744   C0221102:Excretion [Physiologic Function]
   744   C0504085:Excretion [Body Substance]
   744   C1524119:urinary [Qualitative Concept]
   744   C2699704:EXCRETION [Regulation or Law]

Phrase: "(P=0.006"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.92: First urinary albumin excretion >30 g/min had a significantly higher rate of progression to overt nephropathy, compared with urinary albumin excretion between 20 and 30 g/min (9/10 vs 0/3; P<0.001), within the same time of follow-up (respectively 3.72.2 vs 3.31.2 years; P=NS). 

Phrase: "First urinary albumin excretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0042027:Urinary [Body Part, Organ, or Organ Component]
   812   C0221102:Excretion [Physiologic Function]
   812   C0504085:Excretion [Body Substance]
   812   C1524119:urinary [Qualitative Concept]
   812   C2699704:EXCRETION [Regulation or Law]

Phrase: ">30 g/min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0456693:/30 min [Temporal Concept]
   913   C1442458:30 min [Temporal Concept]
   901   C0560021:g/min [Quantitative Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "had"

Phrase: "a significantly higher rate of progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "to overt nephropathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022658:Nephropathy [Disease or Syndrome]

Phrase: "compared with urinary albumin excretion"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0042027:Urinary [Body Part, Organ, or Organ Component]
   760   C0221102:Excretion [Physiologic Function]
   760   C0504085:Excretion [Body Substance]
   760   C1524119:urinary [Qualitative Concept]
   760   C1707455:Compared [Activity]
   760   C2699704:EXCRETION [Regulation or Law]

Phrase: "between 20"

Phrase: "and"

Phrase: "30 g/min (9/10"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C0456693:/30 min [Temporal Concept]
   853   C1442458:30 min [Temporal Concept]
   840   C0560021:g/min [Quantitative Concept]
   804   C0439267:g% [Quantitative Concept]
   804   C0702093:/min [Temporal Concept]

Phrase: "vs"

Phrase: "0/3"

Phrase: "; P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "within the same time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "of follow-up"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0589120:Follow-up [Finding]
  1000   C1522577:follow-up [Health Care Activity]
  1000   C1704685:FOLLOW-UP [Intellectual Product]
  1000   C3274571:FOLLOW-UP [Health Care Activity]
   861   C0332283:follow [Temporal Concept]
   861   C1719822:Follow [Intellectual Product]

Phrase: "(respectively 3.72.2"

Phrase: "vs"

Phrase: "3.31.2 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]

Phrase: "; P=NS)."
Processing 00000000.tx.93: The urinary albumin excretion was initially <30 g/min in the two patients who evolved having UAE <20 g/min at the end of follow-up. 

Phrase: "The urinary albumin excretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0042027:Urinary [Body Part, Organ, or Organ Component]
   827   C0221102:Excretion [Physiologic Function]
   827   C0504085:Excretion [Body Substance]
   827   C1524119:urinary [Qualitative Concept]
   827   C2699704:EXCRETION [Regulation or Law]

Phrase: "was"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "<30 g/min in the two patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0560021:g/min [Quantitative Concept]
   774   C0456693:/30 min [Temporal Concept]
   774   C1442458:30 min [Temporal Concept]
   748   C0702093:/min [Temporal Concept]

Phrase: "who"

Phrase: "evolved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332253:evolved [Functional Concept]

Phrase: "having"

Phrase: "UAE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0042027:Urinary [Body Part, Organ, or Organ Component]
   827   C0221102:Excretion [Physiologic Function]
   827   C0504085:Excretion [Body Substance]
   827   C1524119:urinary [Qualitative Concept]
   827   C2699704:EXCRETION [Regulation or Law]

Phrase: "<20 g/min at the end of follow-up."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0560021:g/min [Quantitative Concept]
   742   C0702093:/min [Temporal Concept]
Processing 00000000.tx.94: View larger version (13K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.95: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.96: Patients with neuropathy: albuminuria and evolution of nephropathy during a mean follow-up of 3.71.9 years. 

Phrase: "Patients with neuropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: ":"

Phrase: "albuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001925:Albuminuria [Finding]

Phrase: "and"

Phrase: "evolution of nephropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0015219:Evolution [Genetic Function]

Phrase: "during a mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "follow-up of 3.71.9 years."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0589120:Follow-up [Finding]
   778   C1522577:follow-up [Health Care Activity]
   778   C1704685:FOLLOW-UP [Intellectual Product]
   778   C3274571:FOLLOW-UP [Health Care Activity]
   748   C0332283:follow [Temporal Concept]
   748   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.97: Numbers of patients with each clinical condition.  

Phrase: "Numbers of patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2360800:Number of patients [Finding]
   841   C1830427:Patient number [Intellectual Product]
   790   C0237753:*Number [Quantitative Concept]
   790   C0449788:Number [Quantitative Concept]

Phrase: "with each clinical condition."
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C0012634:condition [Disease or Syndrome]
   861   C0205210:Clinical [Qualitative Concept]
   861   C0348080:Condition [Qualitative Concept]
   861   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   789 E C0009647:Conditioned [Mental Process]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.98: Overall evolution to overt nephropathy and renal failure In our series, overt nephropathy was found in 16/32 subjects with a previous course of persistent microalbuminuria, but was absent in the 24 subjects maintaining normal urinary albumin excretion (P<0.0001). 

Phrase: "Overall evolution to overt nephropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0015219:Evolution [Genetic Function]

Phrase: "and"

Phrase: "renal failure In our series,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0035078:Renal Failure [Disease or Syndrome]
   806   C1963154:Renal failure [Finding]
   760   C0022646:Renal [Body Part, Organ, or Organ Component]
   760   C0231174:Failure [Functional Concept]
   760   C0680095:failure [Individual Behavior]

Phrase: "overt nephropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022658:Nephropathy [Disease or Syndrome]

Phrase: "was"

Phrase: "found in 16/32 subjects"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0150312:Found [Quantitative Concept]
   726 E C0243095:Find [Finding]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "with a previous course"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750729:Course [Temporal Concept]

Phrase: "of persistent microalbuminuria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "but"

Phrase: "was"

Phrase: "absent in the 24 subjects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:Absent [Quantitative Concept]
   760   C2699517:ABSENT [Finding]

Phrase: "maintaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0024501:Maintain [Activity]

Phrase: "normal urinary albumin excretion"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C0860865:normal albumin [Finding]
   812   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0042027:Urinary [Body Part, Organ, or Organ Component]
   812   C0221102:Excretion [Physiologic Function]
   812   C0504085:Excretion [Body Substance]
   812   C1524119:urinary [Qualitative Concept]
   812   C2699704:EXCRETION [Regulation or Law]

Phrase: "(P<0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.99: The mean time between detection of microalbuminuria and overt nephropathy was 2.01.7 years; 

Phrase: "The mean time between detection of microalbuminuria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0040223:Time [Temporal Concept]
   748   C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "overt nephropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022658:Nephropathy [Disease or Syndrome]

Phrase: "was"

Phrase: "2.01.7 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.100: in these cases, the first determination of albumin excretion was 97.874.6 g/min. 

Phrase: "in these cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "the first determination of albumin excretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1148554:determination [Laboratory Procedure]

Phrase: "was"

Phrase: "97.874.6 g/min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0560021:g/min [Quantitative Concept]
   804   C0702093:/min [Temporal Concept]
Processing 00000000.tx.101: Renal failure was found in five of 16 subjects, and occurred 1-5 years after detection of microalbuminuria; 

Phrase: "Renal failure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035078:Renal Failure [Disease or Syndrome]
  1000   C1963154:Renal failure [Finding]
   861   C0022646:Renal [Body Part, Organ, or Organ Component]
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "was"

Phrase: "found in five of 16 subjects,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0150312:Found [Quantitative Concept]
   753   C0205451:Five [Quantitative Concept]
   719 E C0243095:Find [Finding]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "1-5 years after detection of microalbuminuria"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0439234:years [Temporal Concept]
   714 E C0439508:/year [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.102: in four patients, renal failure developed after overt nephropathy and in one it occurred during the course of microalbuminuria, but was never associated with normal urinary albumin excretion. 

Phrase: "in four patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "renal failure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035078:Renal Failure [Disease or Syndrome]
  1000   C1963154:Renal failure [Finding]
   861   C0022646:Renal [Body Part, Organ, or Organ Component]
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "developed after overt nephropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0022658:Nephropathy [Disease or Syndrome]

Phrase: "and in one"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205447:One [Quantitative Concept]
   790   C1515981:And [Idea or Concept]

Phrase: "it"

Phrase: "occurred during the course of microalbuminuria,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0730345:Microalbuminuria [Disease or Syndrome]
   753   C0750729:Course [Temporal Concept]
   753   C1709305:Occurred [Activity]
   719 E C2745955:OCCUR [Temporal Concept]

Phrase: "but"

Phrase: "was"

Phrase: "never"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003901:Never [Temporal Concept]

Phrase: "associated with normal urinary albumin excretion."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C0860865:albumin normal [Finding]
   753   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0042027:Urinary [Body Part, Organ, or Organ Component]
   753   C0205307:Normal [Qualitative Concept]
   753   C0221102:Excretion [Physiologic Function]
   753   C0439166:% normal [Quantitative Concept]
   753   C0504085:Excretion [Body Substance]
   753   C1524119:urinary [Qualitative Concept]
   753   C2347086:% Normal [Quantitative Concept]
   753   C2699704:EXCRETION [Regulation or Law]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.103: Renal disease, evolution of neuropathy and age Microalbuminuria appeared, on average, after 4.63.8 years of neuropathy (4.13.5 years for women, and 5.84.5 years for men; P<10-4); 

Phrase: "Renal disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0022658:Renal disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0022646:Renal [Body Part, Organ, or Organ Component]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "evolution of neuropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0015219:Evolution [Genetic Function]

Phrase: "and"

Phrase: "age Microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: ","

Phrase: "on average,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510992:Average [Quantitative Concept]
  1000   C2825518:AVERAGE [Quantitative Concept]

Phrase: "after"

Phrase: "4.63.8 years of neuropathy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0439234:years [Temporal Concept]
   719 E C0439508:/year [Temporal Concept]

Phrase: "(4.13.5 years for women,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0439234:years [Temporal Concept]
   719 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "5.84.5 years for men"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0439234:years [Temporal Concept]
   719 E C0439508:/year [Temporal Concept]

Phrase: "; P<10-4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.104: it was most likely to appear during the first years of neuropathy (Figure 3), 78% in the first 7 years. 

Phrase: "it"

Phrase: "was"

Phrase: "most likely to"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0750501:most likely [Idea or Concept]
   827   C0205393:Most [Quantitative Concept]
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]
   755 E C0033204:Likelihood [Quantitative Concept]

Phrase: "appear during the first years of neuropathy"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0205435:First [Quantitative Concept]
   748   C0439234:years [Temporal Concept]
   748   C0442874:Neuropathy [Disease or Syndrome]
   748   C0700364:APPEAR [Qualitative Concept]
   748   C1279901:First [Qualitative Concept]
   714 E C0439508:/year [Temporal Concept]

Phrase: "(Figure 3"

Phrase: ")"

Phrase: ","

Phrase: "78% in the first 7 years."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0205435:First [Quantitative Concept]
   753   C0439234:years [Temporal Concept]
   753   C1279901:First [Qualitative Concept]
   719 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.105: Evolution to clinical nephropathy occurred after a mean duration of neuropathy of 6.84.7 years. 

Phrase: "Evolution to clinical nephropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015219:Evolution [Genetic Function]

Phrase: "occurred after a mean duration of neuropathy"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0442874:Neuropathy [Disease or Syndrome]
   748   C0444504:Mean [Quantitative Concept]
   748   C0449238:Duration [Temporal Concept]
   748   C1709305:Occurred [Activity]
   748   C2347634:Mean [Quantitative Concept]
   748   C2348143:Mean [Quantitative Concept]
   748   C2926735:Duration [Pharmacologic Substance]
   714 E C2745955:OCCUR [Temporal Concept]

Phrase: "of 6.84.7 years."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.106: View larger version (21K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.107: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.108: Distribution of microalbuminuria and nephropathy during evolution of neuropathy in years; 

Phrase: "Distribution of microalbuminuria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520511:distribution [Idea or Concept]
   790   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "nephropathy during evolution of neuropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0022658:Nephropathy [Disease or Syndrome]

Phrase: "in years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439234:years [Temporal Concept]
   966 E C0439508:/year [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.109: negative values represent years before onset of neuropathy. 

Phrase: "negative values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "years before onset of neuropathy."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   824   C3274945:Year of Onset [Temporal Concept]
   760   C0439234:years [Temporal Concept]
   726 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.110: MA, microalbuminuria; 

Phrase: "MA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.111: Neph, proteinuria or renal failure.  

Phrase: "Neph,"

Phrase: "proteinuria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033687:Proteinuria [Finding]
  1000   C1962972:Proteinuria [Finding]

Phrase: "or"

Phrase: "renal failure."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035078:Renal Failure [Disease or Syndrome]
  1000   C1963154:Renal failure [Finding]
   861   C0022646:Renal [Body Part, Organ, or Organ Component]
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]
Processing 00000000.tx.112: The age at onset of neuropathy was not different in subjects with UAE <20 and with 20 g/min (37.811.4 vs 35.611.4 years; P=NS), but when these values were >100 g/min the onset was significantly later (48.014.9 vs 35.610.5 years; P=0.01). 

Phrase: "The age at onset of neuropathy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   753   C0001779:Age [Organism Attribute]
   753   C0332162:Onset [Qualitative Concept]

Phrase: "was"

Phrase: "not different in subjects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]

Phrase: "with UAE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0042027:Urinary [Body Part, Organ, or Organ Component]
   827   C0221102:Excretion [Physiologic Function]
   827   C0504085:Excretion [Body Substance]
   827   C1524119:urinary [Qualitative Concept]
   827   C2699704:EXCRETION [Regulation or Law]

Phrase: "<20"

Phrase: "and with 20 g/min (37.811.4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0560021:g/min [Quantitative Concept]
   744   C0439267:g% [Quantitative Concept]
   744   C0702093:/min [Temporal Concept]
   744   C1515981:And [Idea or Concept]

Phrase: "vs"

Phrase: "35.611.4 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]

Phrase: "; P=NS),"

Phrase: "but"

Phrase: "when"

Phrase: "these values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: ">100 g/min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0560021:g/min [Quantitative Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "was"

Phrase: "significantly later"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205087:Late [Temporal Concept]

Phrase: "(48.014.9"

Phrase: "vs"

Phrase: "35.610.5 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]

Phrase: "; P=0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.113: Patients with neuropathy: albuminuria and evolution of nephropathy during a mean follow-up of 3.71.9 years. 

Phrase: "Patients with neuropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: ":"

Phrase: "albuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001925:Albuminuria [Finding]

Phrase: "and"

Phrase: "evolution of nephropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0015219:Evolution [Genetic Function]

Phrase: "during a mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "follow-up of 3.71.9 years."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0589120:Follow-up [Finding]
   778   C1522577:follow-up [Health Care Activity]
   778   C1704685:FOLLOW-UP [Intellectual Product]
   778   C3274571:FOLLOW-UP [Health Care Activity]
   748   C0332283:follow [Temporal Concept]
   748   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.114: Numbers of patients with each clinical condition. 

Phrase: "Numbers of patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2360800:Number of patients [Finding]
   841   C1830427:Patient number [Intellectual Product]
   790   C0237753:*Number [Quantitative Concept]
   790   C0449788:Number [Quantitative Concept]

Phrase: "with each clinical condition."
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C0012634:condition [Disease or Syndrome]
   861   C0205210:Clinical [Qualitative Concept]
   861   C0348080:Condition [Qualitative Concept]
   861   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   789 E C0009647:Conditioned [Mental Process]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.115: Microalbuminuria and blood pressure We analysed systolic and diastolic blood pressure in asymptomatic carriers and patients with neuropathy, at the beginning of the study and at the end (Tables 1 and 2). 

Phrase: "Microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "and"

Phrase: "blood pressure"
Meta Candidates (Total=16; Excluded=7; Pruned=0; Remaining=9)
  1000   C0005823:Blood Pressure [Organism Function]
  1000   C1271104:Blood Pressure [Finding]
  1000   C1272641:Blood pressure [Finding]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0033095:Pressure [Phenomenon or Process]
   861   C0229664:Blood [Body Substance]
   861   C0460139:Pressure [Finding]
   861   C1306345:Pressure [Functional Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "We"

Phrase: "analysed"

Phrase: "systolic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039155:Systolic [Temporal Concept]

Phrase: "and"

Phrase: "diastolic blood pressure in asymptomatic carriers"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0428883:Diastolic blood pressure [Clinical Attribute]
           Diastolic Pressure
   833   C1305849:diastolic blood pressure [Diagnostic Procedure]
   790   C0005823:Blood Pressure [Organism Function]
   790   C1271104:Blood Pressure [Finding]
   790   C1272641:Blood pressure [Finding]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0012000:Diastolic [Clinical Attribute]
   753   C0033095:Pressure [Phenomenon or Process]
   753   C0229664:Blood [Body Substance]
   753   C0460139:Pressure [Finding]
   753   C1306345:Pressure [Functional Concept]

Phrase: "and"

Phrase: "patients with neuropathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "at the beginning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Beginning [Temporal Concept]

Phrase: "of the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "and at the end (Tables 1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0039224:tables [Manufactured Object]
   753   C0444930:End [Spatial Concept]
   753   C1515981:And [Idea or Concept]
   753   C1706074:Tables [Intellectual Product]
   753   C2746065:End [Temporal Concept]
   719 E C1706073:Table [Medical Device]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.116: Blood pressure lowered when neuropathy was established, even in the presence of microalbuminuria. 

Phrase: "Blood pressure"
Meta Candidates (Total=16; Excluded=7; Pruned=0; Remaining=9)
  1000   C0005823:Blood Pressure [Organism Function]
  1000   C1271104:Blood Pressure [Finding]
  1000   C1272641:Blood pressure [Finding]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0033095:Pressure [Phenomenon or Process]
   861   C0229664:Blood [Body Substance]
   861   C0460139:Pressure [Finding]
   861   C1306345:Pressure [Functional Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "lowered"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0441994:lowered [Spatial Concept]
  1000   C1272755:Lowered [Quantitative Concept]
  1000   C2003888:Lowered [Activity]
   966 E C1548802:Lower [Body Location or Region]

Phrase: "when"

Phrase: "neuropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "was"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: ","

Phrase: "even in the presence of microalbuminuria."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C0730345:Microalbuminuria [Disease or Syndrome]
Processing 00000000.tx.117: Thereafter, renal failure, not just proteinuria, was associated with an increase in systolic and diastolic blood pressure. 

Phrase: "Thereafter,"

Phrase: "renal failure,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035078:Renal Failure [Disease or Syndrome]
  1000   C1963154:Renal failure [Finding]
   861   C0022646:Renal [Body Part, Organ, or Organ Component]
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "not just proteinuria,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033687:Proteinuria [Finding]
   827   C1962972:Proteinuria [Finding]

Phrase: "was"

Phrase: "associated with an increase"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0442805:Increase [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in systolic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039155:Systolic [Temporal Concept]

Phrase: "and"

Phrase: "diastolic blood pressure."
Meta Candidates (Total=20; Excluded=7; Pruned=0; Remaining=13)
  1000   C0428883:Diastolic blood pressure [Clinical Attribute]
           Diastolic Pressure
  1000   C1305849:diastolic blood pressure [Diagnostic Procedure]
   901   C0005823:Blood Pressure [Organism Function]
   901   C1271104:Blood Pressure [Finding]
   901   C1272641:Blood pressure [Finding]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0012000:Diastolic [Clinical Attribute]
   827   C0033095:Pressure [Phenomenon or Process]
   827   C0229664:Blood [Body Substance]
   827   C0460139:Pressure [Finding]
   827   C1306345:Pressure [Functional Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.118: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.119: Clinical data of 54 subjects at the end of follow-up  Serum albumin, lipids, and uric acid Establishment of neuropathy sloped down serum albumin, total serum cholesterol, serum triglycerides, and uric acid. 

Phrase: "Clinical data of 54 subjects"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1516606:Clinical Data [Intellectual Product]
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "at the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of follow-up  Serum albumin,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   861   C0728877:serum albumin [Laboratory or Test Result]
   812   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0229671:Serum [Body Substance]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "lipids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipids [Lipid]

Phrase: "and"

Phrase: "uric acid Establishment of neuropathy"

Phrase: "sloped down serum albumin,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   833   C0728877:serum albumin [Laboratory or Test Result]
   819 E C0523465:Albumin - serum [Laboratory Procedure]
   770   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0229671:Serum [Body Substance]
   770   C0807955:sloped [Quantitative Concept]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]

Phrase: "total serum cholesterol,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C0201950:Total Cholesterol [Laboratory Procedure]
   913   C0543421:Total cholesterol [Steroid]
   901   C0587184:serum cholesterol [Laboratory Procedure]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0229671:Serum [Body Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "serum triglycerides,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0542495:serum triglycerides [Laboratory Procedure]
   861   C0041004:Triglycerides [Biologically Active Substance,Lipid]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "uric acid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041980:Uric Acid [Biologically Active Substance,Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.120: Patients with microalbuminuria had a lower serum albumin level and higher uric acid level, but the same lipid concentration compared to those with normal urinary albumin excretion. 

Phrase: "Patients with microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "had"

Phrase: "a lower serum albumin level"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   923   C0523465:Serum albumin level [Laboratory Procedure]
   923   C0728877:Serum albumin level [Laboratory or Test Result]
           serum albumin
   861   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   861   C0428519:Albumin level [Laboratory or Test Result]
   812   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0229671:Serum [Body Substance]
   812   C0441889:Level [Qualitative Concept]
   812   C0456079:Level [Classification]
   812   C1546774:Serum [Intellectual Product]
   812   C1547707:Level [Geographic Area]
   812   C1550100:Serum [Body Substance]
   812   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "higher uric acid level,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   906   C0920063:high uric acid [Finding]
   861   C0041980:Uric Acid [Biologically Active Substance,Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   812   C0441889:Level [Qualitative Concept]
   812   C0456079:Level [Classification]
   812   C1547707:Level [Geographic Area]
   812   C2946261:Level [Pharmacologic Substance]

Phrase: "but"

Phrase: "the same lipid concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "compared to those with normal urinary albumin excretion."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   767   C0860865:albumin normal [Finding]
   744   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0042027:Urinary [Body Part, Organ, or Organ Component]
   744   C0205307:Normal [Qualitative Concept]
   744   C0221102:Excretion [Physiologic Function]
   744   C0439166:% normal [Quantitative Concept]
   744   C0504085:Excretion [Body Substance]
   744   C1524119:urinary [Qualitative Concept]
   744   C1707455:Compared [Activity]
   744   C2347086:% Normal [Quantitative Concept]
   744   C2699704:EXCRETION [Regulation or Law]
Processing 00000000.tx.121: Progression to overt nephropathy was associated with a tendency toward elevation in serum triglycerides and uric acid, and a decrease in serum albumin; 

Phrase: "Progression to overt nephropathy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]

Phrase: "was"

Phrase: "associated with a tendency"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "toward elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439775:Elevation [Therapeutic or Preventive Procedure]
  1000   C0702240:Elevation [Spatial Concept]

Phrase: "in serum triglycerides"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0542495:serum triglycerides [Laboratory Procedure]
   861   C0041004:Triglycerides [Biologically Active Substance,Lipid]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "uric acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041980:Uric Acid [Biologically Active Substance,Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "a decrease in serum albumin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.122: total cholesterol raised only in the presence of renal failure. 

Phrase: "total cholesterol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0201950:Total Cholesterol [Laboratory Procedure]
  1000   C0543421:Total cholesterol [Steroid]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "raised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442818:Raised [Quantitative Concept]

Phrase: "only in the presence of renal failure."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0035078:Renal Failure [Disease or Syndrome]
   778   C1963154:Renal failure [Finding]
   748   C0022646:Renal [Body Part, Organ, or Organ Component]
   748   C0205171:Only [Quantitative Concept]
   748   C0231174:Failure [Functional Concept]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0680095:failure [Individual Behavior]
   748   C1720467:Only [Intellectual Product]
Processing 00000000.tx.123: Analytic data are shown in Table 2. 

Phrase: "Analytic data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "shown in Table 2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.124: Renal biopsies Renal biopsy was performed in 14 patients, all undergoing liver transplantation: three with normal albumin excretion, seven with microalbuminuria, and four with overt nephropathy after a course of microalbuminuria. 

Phrase: "Renal biopsies Renal biopsy"

Phrase: "was"

Phrase: "performed in 14 patients,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "all"

Phrase: "undergoing"

Phrase: "liver transplantation"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0023911:Liver Transplantation [Therapeutic or Preventive Procedure]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   861   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   861   C0040733:transplantation [Functional Concept]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: ":"

Phrase: "three with normal albumin excretion,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0860865:normal albumin [Finding]
   760   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205307:Normal [Qualitative Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C0221102:Excretion [Physiologic Function]
   760   C0439166:% normal [Quantitative Concept]
   760   C0504085:Excretion [Body Substance]
   760   C2347086:% Normal [Quantitative Concept]
   760   C2699704:EXCRETION [Regulation or Law]

Phrase: "seven with microalbuminuria,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205453:Seven [Quantitative Concept]
   790   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "and"

Phrase: "four with overt nephropathy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0022658:Nephropathy [Disease or Syndrome]
   770   C0205450:Four [Quantitative Concept]

Phrase: "after a course"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750729:Course [Temporal Concept]

Phrase: "of microalbuminuria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]
Processing 00000000.tx.125: Table 3 details the presence and amount of glomerular amyloid deposits. 

Phrase: "Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "details"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1522508:Detail [Qualitative Concept]
  1000   C1561567:detail [Functional Concept]

Phrase: "the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "amount of glomerular amyloid deposits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]
Processing 00000000.tx.126: View this table: [in this window] [in a new window]  Table 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.127: Clinical data and quantification of amyloid in the glomeruli after renal biopsy (n=14)  Normal urinary albumin excretion corresponded to absent or very clear involvement. 

Phrase: "Clinical data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1516606:Clinical Data [Intellectual Product]
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "quantification of amyloid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709793:Quantification [Quantitative Concept]

Phrase: "in the glomeruli"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0022663:Glomerulus [Body Part, Organ, or Organ Component]
   916 E C0268731:GLOMERULAR [Disease or Syndrome]

Phrase: "after renal biopsy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0194073:Renal biopsy [Diagnostic Procedure]
   861   C0005558:Biopsy [Diagnostic Procedure]
   861   C0220797:biopsy [Functional Concept]

Phrase: "(n=14"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "Normal urinary albumin excretion"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C0860865:normal albumin [Finding]
   812   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0042027:Urinary [Body Part, Organ, or Organ Component]
   812   C0221102:Excretion [Physiologic Function]
   812   C0504085:Excretion [Body Substance]
   812   C1524119:urinary [Qualitative Concept]
   812   C2699704:EXCRETION [Regulation or Law]

Phrase: "corresponded to absent"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0332197:Absent [Quantitative Concept]
   790   C2699517:ABSENT [Finding]
   718 E C0424530:Absences [Finding]
   718 E C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "very"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442824:Very [Qualitative Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "involvement."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involvement [Functional Concept]
Processing 00000000.tx.128: The presence of microalbuminuria corresponded to mesangial or vascular pole deposition in all cases. 

Phrase: "The presence of microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "corresponded to mesangial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "vascular pole deposition in all cases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.129: The level of albuminuria generally correlated with the extension of mesangial deposits as described previously [15]. 

Phrase: "The level of albuminuria generally"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "correlated with the extension of mesangial deposits"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0231448:Extension [Functional Concept]
   748   C0333562:Deposits [Functional Concept]
   748   C1707520:Correlated [Qualitative Concept]
   748   C1880641:Extension [Conceptual Entity]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "[15"

Phrase: "]."
Processing 00000000.tx.130: Arterioles of the juxtaglomerular apparatus (vascular pole) were not involved or had only mild deposits when microalbuminuria was <90 g/min. 

Phrase: "Arterioles of the juxtaglomerular apparatus"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0003847:Arterioles [Body Part, Organ, or Organ Component]
   726 E C1282826:Arteriole [Body Part, Organ, or Organ Component]

Phrase: "(vascular pole"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0935623:Pole [Body Location or Region]
   861   C1418729:POLE [Gene or Genome]
   789 E C0813983:polar [Quantitative Concept]
   761 E C0596963:Polarity [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "or"

Phrase: "had"

Phrase: "only mild deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposits [Functional Concept]

Phrase: "when"

Phrase: "microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "was <"

Phrase: "90 g/min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0560021:g/min [Quantitative Concept]
   827   C0702093:/min [Temporal Concept]
Processing 00000000.tx.131: In one patient with overt nephropathy, who entered the study as an asymptomatic carrier with microalbuminuria, we observed a less extensive mesangial deposition when compared with other patients with microalbuminuria: he had amyloid vascular deposits in the arterioles and interlobular arteries, and deposition in subendothelial spaces. 

Phrase: "In one patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "with overt nephropathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022658:Nephropathy [Disease or Syndrome]

Phrase: "who"

Phrase: "entered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521975:Entered [Qualitative Concept]
   966 E C1522196:ENTER [Functional Concept]

Phrase: "the study as an asymptomatic carrier"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "with microalbuminuria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a less extensive mesangial deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0333562:Deposition [Functional Concept]

Phrase: "when"

Phrase: "compared with other patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C1707455:Compared [Activity]

Phrase: "with microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: ":"

Phrase: "he"

Phrase: "had"

Phrase: "amyloid vascular deposits in the arterioles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C2936349:Amyloid Deposits [Acquired Abnormality]
   753   C0333562:Deposits [Functional Concept]

Phrase: "and"

Phrase: "interlobular arteries,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C1512856:Interlobular Artery [Body Part, Organ, or Organ Component]
   861   C0003842:Arteries [Body Part, Organ, or Organ Component]
   861   C0226004:arteries [Body System]
   777 E C0221464:Arterial [Spatial Concept]

Phrase: "and"

Phrase: "deposition in subendothelial spaces."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.132: We never found glomerular or vascular lesions other than amyloid deposits.  

Phrase: "We never"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003901:Never [Temporal Concept]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "glomerular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022663:Glomerular [Body Part, Organ, or Organ Component]
  1000   C0268731:GLOMERULAR [Disease or Syndrome]

Phrase: "or"

Phrase: "vascular lesions other than amyloid deposits."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1402315:Vascular lesions [Disease or Syndrome]
   753   C0221198:lesions [Finding]
   719 E C1546698:Lesion [Intellectual Product]
Processing 00000000.tx.133: Discussion Top Abstract Introduction Subjects and methods Results Discussion References  The most frequent presentation of amyloid nephropathy is proteinuria, with variable degrees of renal insufficiency [17]. 

Phrase: "Discussion Top Abstract Introduction Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   771   C0681850:Subject [Group]
   771   C1550501:{Subject} [Idea or Concept]
   771   C1706203:Subject [Idea or Concept]
   771   C2349001:Subject [Human]
   771   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The most frequent presentation of amyloid nephropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449450:Presentation [Idea or Concept]

Phrase: "is"

Phrase: "proteinuria,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033687:Proteinuria [Finding]
  1000   C1962972:Proteinuria [Finding]

Phrase: "with variable degrees"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0449286:degrees [Quantitative Concept]
   861   C0542560:degrees [Intellectual Product]
   827 E C0441889:Degree [Qualitative Concept]
   827 E C1561545:degree [Quantitative Concept]
   827 E C2348088:Degree [Quantitative Concept]

Phrase: "of renal insufficiency"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0035078:Renal insufficiency [Disease or Syndrome]
  1000   C1565489:Renal Insufficiency [Disease or Syndrome]
   861   C0022646:Renal [Body Part, Organ, or Organ Component]
   861   C0231179:Insufficiency [Functional Concept]
   789 E C0205412:Insufficient [Qualitative Concept]
   789 E C0231180:Insufficient [Qualitative Concept]

Phrase: "[17"

Phrase: "]."
Processing 00000000.tx.134: Although the pathogenic mechanism in diabetes and amyloid nephropathy are different, some common structural defects [18] could have similar consequences. 

Phrase: "Although"

Phrase: "the pathogenic mechanism in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "amyloid nephropathy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268382:Amyloid nephropathy [Disease or Syndrome]
   861   C0022658:Nephropathy [Disease or Syndrome]

Phrase: "are"

Phrase: "different,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]

Phrase: "some common structural defects"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0243067:defects [Functional Concept]
   793 E C1457869:Defect [Functional Concept]
   793 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "[18"

Phrase: "]"

Phrase: "could"

Phrase: "have"

Phrase: "similar consequences."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0686907:consequences [Functional Concept]
Processing 00000000.tx.135: Increased protein excretion, manifested as microalbuminuria, is the earliest clinical finding of diabetic nephropathy [19]. 

Phrase: "Increased protein excretion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0221102:Excretion [Physiologic Function]
   827   C0504085:Excretion [Body Substance]
   827   C2699704:EXCRETION [Regulation or Law]

Phrase: "manifested as microalbuminuria,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205319:manifested [Functional Concept]
   790   C0730345:Microalbuminuria [Disease or Syndrome]
   790   C1280444:manifested [Qualitative Concept]

Phrase: "is"

Phrase: "the earliest clinical finding of diabetic nephropathy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0037088:Clinical finding [Sign or Symptom]
           Finding
   778   C3540840:Clinical Finding [Finding]
   748   C0243095:Finding [Finding]
   748   C2825141:Finding [Finding]

Phrase: "[19"

Phrase: "]."
Processing 00000000.tx.136: These observations prompted investigation of urinary albumin excretion in ATTR Val30Met amyloidosis. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "prompted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871157:prompted [Functional Concept]
   966 E C1602245:Prompt [Pharmacologic Substance]

Phrase: "investigation of urinary albumin excretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261322:Investigation [Health Care Activity]
   760   C1552578:investigation [Idea or Concept]

Phrase: "in ATTR Val30Met amyloidosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002726:Amyloidosis [Disease or Syndrome]
Processing 00000000.tx.137: Microalbuminuria precedes neuropathy and overt renal disease In the current study, the diagnosis of microalbuminuria prior to the first complaints of FAP, was made in 32 percent of carriers. 

Phrase: "Microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "precedes"

Phrase: "neuropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "and"

Phrase: "overt renal disease In the current study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0022658:Renal disease [Disease or Syndrome]
   774   C0846101:renal study [Diagnostic Procedure]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0022646:Renal [Body Part, Organ, or Organ Component]

Phrase: "the diagnosis of microalbuminuria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011900:Diagnosis [Finding]
   770   C1704338:diagnosis [Qualitative Concept]
   770   C1704656:DIAGNOSIS [Research Activity]

Phrase: "prior to the first complaints"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0277786:complaints [Finding]

Phrase: "of FAP,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0206245:Familial amyloid polyneuropathy [Disease or Syndrome]
  1000   C2751492:AMYLOID POLYNEUROPATHY, FAMILIAL [Disease or Syndrome]
   913   C0751448:Polyneuropathy, Familial [Disease or Syndrome]
   901   C0206247:Amyloid polyneuropathy [Disease or Syndrome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0015576:familial [Family Group]
   827   C0152025:Polyneuropathy [Disease or Syndrome]
   827   C0241888:Familial [Functional Concept]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "was"

Phrase: "made in 32 percent of carriers."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0007294:carriers [Finding]
   753   C0439165:Percent [Quantitative Concept]
   719 E C0560175:Carrier [Finding]
   719 E C1706209:Carrier [Medical Device]
   719   C1881534:Make [Functional Concept]
   719 E C3273162:Carrier [Intellectual Product]
Processing 00000000.tx.138: The presence of microalbuminuria in asymptomatic gene carriers, compared with those having normal urinary albumin excretion, gave a 4.8-fold risk of developing neuropathy, usually within the next 3 years. 

Phrase: "The presence of microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in asymptomatic gene carriers,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0007294:carriers [Finding]
   793 E C0560175:Carrier [Finding]
   793 E C1706209:Carrier [Medical Device]
   793 E C3273162:Carrier [Intellectual Product]

Phrase: "compared with those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "having"

Phrase: "normal urinary albumin excretion,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C0860865:normal albumin [Finding]
   812   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0042027:Urinary [Body Part, Organ, or Organ Component]
   812   C0221102:Excretion [Physiologic Function]
   812   C0504085:Excretion [Body Substance]
   812   C1524119:urinary [Qualitative Concept]
   812   C2699704:EXCRETION [Regulation or Law]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "a 4.8-fold risk of developing neuropathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0035647:Risk [Qualitative Concept]

Phrase: "usually within the next 3 years."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0205117:next [Spatial Concept]
   753   C0332282:Next [Temporal Concept]
   753   C0439234:years [Temporal Concept]
   753   C1883708:Next [Temporal Concept]
   719 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.139: The follow-up of individuals at risk showed that once neurological signs have appeared, nephropathy (manifested as early microalbuminuria) progressed to overt renal disease in almost one-half of the cases. 

Phrase: "The follow-up of individuals"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0589120:Follow-up [Finding]
   806   C1522577:follow-up [Health Care Activity]
   806   C1704685:FOLLOW-UP [Intellectual Product]
   806   C3274571:FOLLOW-UP [Health Care Activity]
   760   C0332283:follow [Temporal Concept]
   760   C1719822:Follow [Intellectual Product]

Phrase: "at risk"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1444641:At risk [Qualitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C1516077:At [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "once"

Phrase: "neurological signs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0220912:signs [Functional Concept]
   861   C0220913:signs [Manufactured Object]
   861   C0311392:SIGNS [Finding]
   827 E C1547188:Sign [Idea or Concept]

Phrase: "have"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: ","

Phrase: "nephropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022658:Nephropathy [Disease or Syndrome]

Phrase: "("

Phrase: "manifested as early microalbuminuria"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205319:manifested [Functional Concept]
   770   C0730345:Microalbuminuria [Disease or Syndrome]
   770   C1279919:Early [Temporal Concept]
   770   C1280444:manifested [Qualitative Concept]

Phrase: ")"

Phrase: "progressed to overt renal disease"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   806   C0022658:Renal disease [Disease or Syndrome]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0022646:Renal [Body Part, Organ, or Organ Component]
   760   C1272688:progressed [Functional Concept]
   726 E C1280477:Progress [Functional Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "in almost one-half"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2825407:Half [Quantitative Concept]

Phrase: "of the cases."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.140: The analysis of subjects that already had neuropathy when microalbuminuria was detected showed also that one-half developed overt nephropathy later. 

Phrase: "The analysis of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "that already"

Phrase: "had"

Phrase: "neuropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "when"

Phrase: "microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "also"

Phrase: "that one-half"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2825407:Half [Quantitative Concept]

Phrase: "developed"

Phrase: "overt nephropathy later."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022658:Nephropathy [Disease or Syndrome]
Processing 00000000.tx.141: Progression to clinical nephropathy was associated with urinary albumin excretion levels >30 mg/min, which probably has a higher discriminatory value for predicting outcome than the level of 20 g/min. 

Phrase: "Progression to clinical nephropathy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]

Phrase: "was"

Phrase: "associated with urinary albumin excretion levels"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C0243173:urinary levels [Functional Concept]
   783   C0428519:albumin levels [Laboratory or Test Result]
   753   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0042027:Urinary [Body Part, Organ, or Organ Component]
   753   C0221102:Excretion [Physiologic Function]
   753   C0441889:Levels [Qualitative Concept]
   753   C0504085:Excretion [Body Substance]
   753   C1524119:urinary [Qualitative Concept]
   753   C2699704:EXCRETION [Regulation or Law]
   719 E C0456079:Level [Classification]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1547707:Level [Geographic Area]
   719 E C1706221:Associate [Professional or Occupational Group]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: ">30 mg/min,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0456693:/30 min [Temporal Concept]
   913   C1442458:30 min [Temporal Concept]
   901   C0439420:mg/min [Quantitative Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "which probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "has"

Phrase: "a higher discriminatory value for predicting outcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1522609:Value [Quantitative Concept]

Phrase: "than the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of 20 g/min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0560021:g/min [Quantitative Concept]
   827   C0702093:/min [Temporal Concept]
Processing 00000000.tx.142: Levels of urinary albumin excretion >100 g/min at presentation occurred in patients with later onset of neuropathy, so special attention must be devoted to follow-up of older subjects. 

Phrase: "Levels of urinary albumin excretion"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   797   C0243173:urinary levels [Functional Concept]
   797   C0428519:albumin levels [Laboratory or Test Result]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: ">100 g/min at presentation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0560021:g/min [Quantitative Concept]
   760   C0702093:/min [Temporal Concept]

Phrase: "occurred in patients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1709305:Occurred [Activity]
   756 E C2745955:OCCUR [Temporal Concept]

Phrase: "with later onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332162:Onset [Qualitative Concept]

Phrase: "of neuropathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "so"

Phrase: "special attention"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004268:Attention [Mental Process]

Phrase: "must"

Phrase: "be"

Phrase: "devoted"

Phrase: "to follow-up of older subjects."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0589120:Follow-up [Finding]
   790   C1522577:follow-up [Health Care Activity]
   790   C1704685:FOLLOW-UP [Intellectual Product]
   790   C3274571:FOLLOW-UP [Health Care Activity]
   753   C0332283:follow [Temporal Concept]
   753   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.143: Subjects maintaining normal urinary albumin excretion during the follow-up did not evolve to clinical nephropathy. 

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "maintaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0024501:Maintain [Activity]

Phrase: "normal urinary albumin excretion during the follow-up"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C0860865:albumin normal [Finding]
   744   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0042027:Urinary [Body Part, Organ, or Organ Component]
   744   C0221102:Excretion [Physiologic Function]
   744   C0504085:Excretion [Body Substance]
   744   C1524119:urinary [Qualitative Concept]
   744   C2699704:EXCRETION [Regulation or Law]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "evolve to clinical nephropathy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0022658:Nephropathy [Disease or Syndrome]
   770   C0205210:Clinical [Qualitative Concept]
Processing 00000000.tx.144: Time between detection of microalbuminuria and overt renal disease was 2 years. 

Phrase: "Time between detection of microalbuminuria"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0040223:Time [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "overt renal disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0022658:Renal disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0022646:Renal [Body Part, Organ, or Organ Component]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "2 years."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.145: First urinary albumin excretion had a level near 100 mg/min on those who progressed, suggesting that a higher interval of progression from sub-clinical to overt nephropathy could have been obtained if our starting point had been earlier. 

Phrase: "First urinary albumin excretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0042027:Urinary [Body Part, Organ, or Organ Component]
   812   C0221102:Excretion [Physiologic Function]
   812   C0504085:Excretion [Body Substance]
   812   C1524119:urinary [Qualitative Concept]
   812   C2699704:EXCRETION [Regulation or Law]

Phrase: "had"

Phrase: "a level near 100 mg/min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "on those"

Phrase: "who"

Phrase: "progressed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1272688:progressed [Functional Concept]
   966 E C1280477:Progress [Functional Concept]

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a higher interval of progression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1272706:Interval [Temporal Concept]
   760   C1552654:Interval [Idea or Concept]
   760   C1552713:Interval [Intellectual Product]

Phrase: "from sub-clinical"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205210:Clinical [Qualitative Concept]
   861   C0542339:Sub- [Spatial Concept]
   861   C1264637:SUB [Quantitative Concept]

Phrase: "to overt nephropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022658:Nephropathy [Disease or Syndrome]

Phrase: "could"

Phrase: "have"

Phrase: "been"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "if"

Phrase: "our starting point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]

Phrase: "had"

Phrase: "been"

Phrase: "earlier."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]
Processing 00000000.tx.146: We think it is advisable that an asymptomatic gene carrier with repeated urinary albumin excretion >30 g/min should be put on a liver transplant list. 

Phrase: "We"

Phrase: "think"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:think [Mental Process]

Phrase: "it"

Phrase: "is"

Phrase: "advisable"

Phrase: "that"

Phrase: "an asymptomatic gene carrier with repeated urinary albumin excretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0007294:Carrier [Finding]
   742   C0560175:Carrier [Finding]
   742   C1706209:Carrier [Medical Device]
   742   C3273162:Carrier [Intellectual Product]

Phrase: ">30 g/min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0456693:/30 min [Temporal Concept]
   913   C1442458:30 min [Temporal Concept]
   901   C0560021:g/min [Quantitative Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "should"

Phrase: "be"

Phrase: "put on a liver transplant list."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0023911:Liver Transplant [Therapeutic or Preventive Procedure]
   790   C0040746:Liver transplant [Body Part, Organ, or Organ Component]
   753   C0023884:Liver [Body Part, Organ, or Organ Component]
   753   C0040732:Transplant [Therapeutic or Preventive Procedure]
   753   C0332835:Transplant [Tissue]
   753   C0736268:LIVER [Body Part, Organ, or Organ Component]
   753   C0745732:List [Conceptual Entity]
   753   C1278929:Liver [Body Part, Organ, or Organ Component]
   753   C1882509:Put [Activity]
   753   C2346688:LIVER [Food]
   753   C3272378:LIST [Intellectual Product]
Processing 00000000.tx.147: Renal failure occurring after a course of microalbuminuria Renal failure on TTR Val30Met amyloidosis developed in 18.8% of the subjects with a previous course of microalbuminuria and in one-third of those with overt nephropathy, but did not emerge with normal urinary albumin excretion. 

Phrase: "Renal failure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035078:Renal Failure [Disease or Syndrome]
  1000   C1963154:Renal failure [Finding]
   861   C0022646:Renal [Body Part, Organ, or Organ Component]
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "occurring after a course of microalbuminuria Renal failure"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0035078:Renal Failure [Disease or Syndrome]
   770   C1963154:Renal failure [Finding]
   744   C0022646:Renal [Body Part, Organ, or Organ Component]
   744   C0231174:Failure [Functional Concept]
   744   C0680095:failure [Individual Behavior]
   744   C0730345:Microalbuminuria [Disease or Syndrome]
   744   C0750729:Course [Temporal Concept]
   711   C1709305:Occur [Activity]
   711   C2745955:OCCUR [Temporal Concept]

Phrase: "on TTR Val30Met amyloidosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0268407:transthyretin amyloidosis [Disease or Syndrome]
   913   C2751492:Transthyretin Amyloidosis [Disease or Syndrome]
   827   C0002726:Amyloidosis [Disease or Syndrome]

Phrase: "developed in 18.8% of the subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]

Phrase: "with a previous course"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750729:Course [Temporal Concept]

Phrase: "of microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "and in one-third of those with overt nephropathy,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0022658:Nephropathy [Disease or Syndrome]
   742   C0205437:Third [Quantitative Concept]
   742   C0205447:One [Quantitative Concept]
   742   C1515981:And [Idea or Concept]

Phrase: "but"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "emerge with normal urinary albumin excretion."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C0860865:albumin normal [Finding]
   753   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0042027:Urinary [Body Part, Organ, or Organ Component]
   753   C0205307:Normal [Qualitative Concept]
   753   C0221102:Excretion [Physiologic Function]
   753   C0439166:% normal [Quantitative Concept]
   753   C0504085:Excretion [Body Substance]
   753   C1524119:urinary [Qualitative Concept]
   753   C2347086:% Normal [Quantitative Concept]
   753   C2699704:EXCRETION [Regulation or Law]
Processing 00000000.tx.148: Renal failure always occurred after neuropathy began. 

Phrase: "Renal failure always"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0035078:Renal Failure [Disease or Syndrome]
   901   C1963154:Renal failure [Finding]
   827   C0022646:Renal [Body Part, Organ, or Organ Component]
   827   C0231174:Failure [Functional Concept]
   827   C0680095:failure [Individual Behavior]

Phrase: "occurred after neuropathy"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0442874:Neuropathy [Disease or Syndrome]
   790   C1709305:Occurred [Activity]
   756 E C2745955:OCCUR [Temporal Concept]

Phrase: "began."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]
Processing 00000000.tx.149: Microalbuminuria was not associated with an increase in blood pressure or dyslipidaemia FAP patients with microalbuminuria did not show an increase in blood pressure or serum lipids; 

Phrase: "Microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with an increase"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0442805:Increase [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in blood pressure"
Meta Candidates (Total=16; Excluded=7; Pruned=0; Remaining=9)
  1000   C0005823:Blood Pressure [Organism Function]
  1000   C1271104:Blood Pressure [Finding]
  1000   C1272641:Blood pressure [Finding]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0033095:Pressure [Phenomenon or Process]
   861   C0229664:Blood [Body Substance]
   861   C0460139:Pressure [Finding]
   861   C1306345:Pressure [Functional Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "or"

Phrase: "dyslipidaemia FAP patients with microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030705:Patients [Patient or Disabled Group]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "an increase in blood pressure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   926   C0497247:Increase in blood pressure [Finding]
           blood pressure increase
   844   C0677038:Increase in pressure [Phenomenon or Process]
           increase pressure
   844   C1881187:INCREASE IN PRESSURE [Phenomenon or Process]
   760   C0442805:Increase [Functional Concept]

Phrase: "or"

Phrase: "serum lipids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0428462:Serum lipids NOS [Laboratory Procedure]
   861   C0023779:Lipids [Lipid]

Phrase: ";"
Processing 00000000.tx.150: only overt nephropathy later changed these parameters. 

Phrase: "only overt nephropathy later"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0022658:Nephropathy [Disease or Syndrome]

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "these parameters."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0449381:Parameters [Finding]
   966 E C0549193:Parameter [Spatial Concept]
   966 E C1704769:Parameter [Conceptual Entity]
   966 E C2350001:Parameter [Quantitative Concept]
Processing 00000000.tx.151: We did not register either the highly significant effect of hypertension on microalbuminuria of FAP, as seen in diabetes mellitus [20], or the association to hyperlipidaemia as described in essential hypertension [21]. 

Phrase: "We"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "register"

Phrase: "either"

Phrase: "the highly significant effect of hypertension"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "of FAP,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0206245:Familial amyloid polyneuropathy [Disease or Syndrome]
  1000   C2751492:AMYLOID POLYNEUROPATHY, FAMILIAL [Disease or Syndrome]
   913   C0751448:Polyneuropathy, Familial [Disease or Syndrome]
   901   C0206247:Amyloid polyneuropathy [Disease or Syndrome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0015576:familial [Family Group]
   827   C0152025:Polyneuropathy [Disease or Syndrome]
   827   C0241888:Familial [Functional Concept]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "as"

Phrase: "seen in diabetes mellitus"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "[20"

Phrase: "],"

Phrase: "or"

Phrase: "the association to hyperlipidaemia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "as"

Phrase: "described in essential hypertension"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0085580:Essential Hypertension [Disease or Syndrome]
   770   C0020538:Hypertension [Disease or Syndrome]
   770   C0205224:Essential [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C1963138:Hypertension [Finding]

Phrase: "[21"

Phrase: "]."
Processing 00000000.tx.152: Other risk factors for early nephropathy in FAP should be investigated. 

Phrase: "Other risk factors for early nephropathy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0035648:risk factors [Quantitative Concept]
   790   C1553898:risk factors [Idea or Concept]
   753   C0035647:Risk [Qualitative Concept]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "in FAP"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0206245:Familial amyloid polyneuropathy [Disease or Syndrome]
  1000   C2751492:AMYLOID POLYNEUROPATHY, FAMILIAL [Disease or Syndrome]
   913   C0751448:Polyneuropathy, Familial [Disease or Syndrome]
   901   C0206247:Amyloid polyneuropathy [Disease or Syndrome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0015576:familial [Family Group]
   827   C0152025:Polyneuropathy [Disease or Syndrome]
   827   C0241888:Familial [Functional Concept]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "should"

Phrase: "be"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.153: Modifications of the transthyretin catabolism or intracellular environment, interactions of the amyloid precursor with mesangium or basement membrane components may represent the clues for renal disease. 

Phrase: "Modifications of the transthyretin catabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0392747:Modification [Functional Concept]
   726   C1554963:modification [Qualitative Concept]

Phrase: "or"

Phrase: "intracellular environment,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014406:Environment [Spatial Concept]

Phrase: "interactions of the amyloid precursor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "with mesangium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "basement membrane components"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0449432:Components [Manufactured Object]
   793 E C1705248:Component [Conceptual Entity]
   734   C0004799:Basement membrane [Tissue]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the clues for renal disease."
Processing 00000000.tx.154: The extent of glomerular amyloid deposits was related to microalbuminuria The amount of mesangial and vascular pole amyloid deposits showed correlation with the level of albumin in the urine. 

Phrase: "The extent of glomerular amyloid deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439792:Extent [Spatial Concept]

Phrase: "was"

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "to microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "The amount of mesangial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "vascular pole amyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2936349:Amyloid Deposits [Acquired Abnormality]
   812   C0333562:Deposits [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "correlation with the level of albumin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707520:Correlation [Qualitative Concept]

Phrase: "in the urine."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042036:Urine [Body Substance]
  1000   C0042037:urine [Functional Concept]
  1000   C2963137:Urine [Body Substance]
Processing 00000000.tx.155: The arterioles of the juxtaglomerular apparatus were more extensively involved when microalbuminuria was >90 mg/min. 

Phrase: "The arterioles of the juxtaglomerular apparatus"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0003847:Arterioles [Body Part, Organ, or Organ Component]
   719 E C1282826:Arteriole [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "more extensively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "when"

Phrase: "microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "was >"

Phrase: "90 mg/min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439420:mg/min [Quantitative Concept]
   827   C0702093:/min [Temporal Concept]
Processing 00000000.tx.156: Therefore, although hypertension was not related with microalbuminuria, vascular pole amyloidosis may have a functional impact on glomerular capillary pressure and a prognostic value for the evolution of nephropathy. 

Phrase: "Therefore,"

Phrase: "although"

Phrase: "hypertension"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020538:Hypertension [Disease or Syndrome]
  1000   C1963138:Hypertension [Finding]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "related with microalbuminuria,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0439849:Related [Qualitative Concept]
   790   C0445223:Related [Finding]
   790   C0730345:Microalbuminuria [Disease or Syndrome]
   756 E C0163712:Relate [Organic Chemical]

Phrase: "vascular pole amyloidosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002726:Amyloidosis [Disease or Syndrome]

Phrase: "may"

Phrase: "have"

Phrase: "a functional impact on glomerular capillary pressure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1825598:IMPACT [Gene or Genome]

Phrase: "and"

Phrase: "a prognostic value for the evolution of nephropathy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1522609:Value [Quantitative Concept]
Processing 00000000.tx.157: Autonomic dysfunction did not explain microalbuminuria. 

Phrase: "Autonomic dysfunction"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0741307:Autonomic dysfunction [Pathologic Function]
   861   C0004388:Autonomic [Body System]
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "explain"

Phrase: "microalbuminuria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]
Processing 00000000.tx.158: In other diseases with autonomic dysfunction such as familial dysautonomia (RileyDay syndrome), lower creatinine clearances were related to disturbed renal haemodynamics, not to specific glomerular disease [22]. 

Phrase: "In other diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "with autonomic dysfunction"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0741307:Autonomic dysfunction [Pathologic Function]
   861   C0004388:Autonomic [Body System]
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "such as familial dysautonomia"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0013364:Dysautonomia, Familial [Congenital Abnormality,Disease or Syndrome]
   861   C0013363:Dysautonomia [Disease or Syndrome]
   861   C0015576:familial [Family Group]
   861   C0241888:Familial [Functional Concept]
   861   C1145628:dysautonomia [Disease or Syndrome]
   789 E C1704727:Family [Conceptual Entity]

Phrase: "(RileyDay syndrome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039082:Syndrome [Disease or Syndrome]

Phrase: ")"

Phrase: ","

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "creatinine clearances"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0812399:Creatinine clearance [Finding]
   861   C0010294:Creatinine [Biologically Active Substance,Organic Chemical]
   861   C1561535:Creatinine [Finding]
   827   C0449297:Clearance [Qualitative Concept]
   827   C1382187:Clearance [Clinical Attribute]
   827   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "were"

Phrase: "related to disturbed renal haemodynamics,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0019010:Hemodynamics [Organ or Tissue Function]
   760   C0022646:Renal [Body Part, Organ, or Organ Component]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "not to specific glomerular disease"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0268731:Glomerular disease [Disease or Syndrome]
           GLOMERULAR
   760   C0012634:Disease [Disease or Syndrome]
   760   C0022663:Glomerular [Body Part, Organ, or Organ Component]
   760   C0205369:Specific [Qualitative Concept]
   760   C1518422:Not [Functional Concept]
   760   C1552740:specific [Intellectual Product]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "[22"

Phrase: "]."
Processing 00000000.tx.159: A study of renal disease in familial dysautonomia [23] identified excess glomerulosclerosis as a frequent finding on autopsy or biopsy cases; 

Phrase: "A study of renal disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0846101:renal study [Diagnostic Procedure]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]

Phrase: "in familial dysautonomia"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0013364:Dysautonomia, Familial [Congenital Abnormality,Disease or Syndrome]
   861   C0013363:Dysautonomia [Disease or Syndrome]
   861   C0015576:familial [Family Group]
   861   C0241888:Familial [Functional Concept]
   861   C1145628:dysautonomia [Disease or Syndrome]
   789 E C1704727:Family [Conceptual Entity]

Phrase: "[23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "]"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "excess glomerulosclerosis as a frequent finding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0178664:Glomerulosclerosis [Disease or Syndrome]
   753   C1417247:glomerulosclerosis [Gene or Genome]

Phrase: "on autopsy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004398:Autopsy [Diagnostic Procedure]

Phrase: "or"

Phrase: "biopsy cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.160: renal disease was attributed to ischaemia due to hypotension and subsequent sclerosis of glomeruli. 

Phrase: "renal disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0022658:Renal disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0022646:Renal [Body Part, Organ, or Organ Component]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "attributed to ischaemia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0022116:Ischaemia [Disease or Syndrome]
   756   C0449234:Attribute [Idea or Concept]
   756   C1704772:Attribute [Conceptual Entity]
   756   C1882133:Attribute [Qualitative Concept]
   718 E C0475224:Ischaemic [Functional Concept]

Phrase: "due to hypotension"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020649:Hypotension [Finding]
  1000   C3163620:Hypotension [Pathologic Function]

Phrase: "and"

Phrase: "subsequent sclerosis of glomeruli."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   777   C0178664:Glomerular sclerosis [Disease or Syndrome]
   770   C0036429:Sclerosis [Pathologic Function]
Processing 00000000.tx.161: Our biopsy findings in patients with microalbuminuria did not reveal sclerosis of glomeruli, suggesting that albumin excretion did not correlate with ischaemia. 

Phrase: "Our biopsy findings in patients"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C1287401:biopsy findings [Laboratory or Test Result]
   760   C2607943:findings [Functional Concept]
   760   C2926606:Findings [Clinical Attribute]
   760   C3539655:Findings [Intellectual Product]
   726 E C0037088:Finding [Sign or Symptom]
   726 E C0243095:Finding [Finding]
   726 E C2825141:Finding [Finding]

Phrase: "with microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "sclerosis of glomeruli,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   816   C0178664:Glomerular sclerosis [Disease or Syndrome]
   790   C0036429:Sclerosis [Pathologic Function]
   718 E C0334135:Sclerotic [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that albumin excretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0221102:Excretion [Physiologic Function]
   861   C0504085:Excretion [Body Substance]
   861   C2699704:EXCRETION [Regulation or Law]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "correlate with ischaemia."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0022116:Ischaemia [Disease or Syndrome]
   718 E C0475224:Ischaemic [Functional Concept]
Processing 00000000.tx.162: Variation on renal haemodynamics, however, can explain how two patients with microalbuminuria reached the end of follow-up with normal albuminuria, although both had had urinary albumin excretion levels <30 g/min at first determination. 

Phrase: "Variation on renal haemodynamics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205419:Variation [Qualitative Concept]

Phrase: "however,"

Phrase: "can"

Phrase: "explain"

Phrase: "how two patients with microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "the end of follow-up"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0444930:End [Spatial Concept]
   760   C2746065:End [Temporal Concept]
   704 E C0205088:Terminal [Temporal Concept]
   704 E C1705314:Terminal [Manufactured Object]
   704 E C1705315:Terminal [Spatial Concept]

Phrase: "with normal albuminuria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001925:Albuminuria [Finding]

Phrase: "although"

Phrase: "both"

Phrase: "had"

Phrase: "had"

Phrase: "urinary albumin excretion levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   902   C0243173:urinary levels [Functional Concept]
   875   C0428519:albumin levels [Laboratory or Test Result]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "<30 g/min at first determination."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0560021:g/min [Quantitative Concept]
   783   C0456693:/30 min [Temporal Concept]
   783   C1442458:30 min [Temporal Concept]
   753   C0702093:/min [Temporal Concept]
Processing 00000000.tx.163: This fact reinforces the discrimination value of albuminuria >30 g/min in predicting outcome. 

Phrase: "This fact"

Phrase: "reinforces"

Phrase: "the discrimination value of albuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1522609:Value [Quantitative Concept]

Phrase: ">30 g/min in predicting outcome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0560021:g/min [Quantitative Concept]
   783   C0456693:/30 min [Temporal Concept]
   783   C1442458:30 min [Temporal Concept]
   753   C0702093:/min [Temporal Concept]
Processing 00000000.tx.164: Autonomic symptoms can become manifest after the onset of FAP, and dysautonomia becomes more severe as the disease progresses. 

Phrase: "Autonomic symptoms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2674101:Autonomic symptoms [Finding]
   861   C0683368:symptoms [Functional Concept]
   861   C1457887:Symptoms [Sign or Symptom]

Phrase: "can"

Phrase: "become"

Phrase: "manifest after the onset of FAP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205319:Manifest [Functional Concept]

Phrase: "and"

Phrase: "dysautonomia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013363:Dysautonomia [Disease or Syndrome]
  1000   C1145628:dysautonomia [Disease or Syndrome]

Phrase: "becomes"

Phrase: "more severe as the disease progresses."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205082:Severe [Qualitative Concept]
Processing 00000000.tx.165: However, microalbuminuria and subsequent nephropathy occur mostly during the first 7 years of FAP, with new cases sparsely thereafter. 

Phrase: "However,"

Phrase: "microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "and"

Phrase: "subsequent nephropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022658:Nephropathy [Disease or Syndrome]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "mostly during the first 7 years of FAP,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   782   C0206245:Familial amyloid polyneuropathy [Disease or Syndrome]
   782   C2751492:AMYLOID POLYNEUROPATHY, FAMILIAL [Disease or Syndrome]
   760   C0206247:Amyloid polyneuropathy [Disease or Syndrome]
   757   C0751448:Polyneuropathy, Familial [Disease or Syndrome]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0015576:familial [Family Group]
   739   C0152025:Polyneuropathy [Disease or Syndrome]
   739   C0205435:First [Quantitative Concept]
   739   C0241888:Familial [Functional Concept]
   739   C0439234:years [Temporal Concept]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0750554:mostly [Idea or Concept]
   739   C1279901:First [Qualitative Concept]
   706 E C0439508:/year [Temporal Concept]

Phrase: "with new cases sparsely thereafter."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0205314:New [Temporal Concept]
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.166: In summary, the findings of the current study are consistent with the conclusion that microalbuminuria represents a first stage of clinical amyloid nephropathy and could be premonitory of neuropathy. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "the findings of the current study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   783   C0683954:study findings [Finding]
   753   C2607943:findings [Functional Concept]
   753   C2926606:Findings [Clinical Attribute]
   753   C3539655:Findings [Intellectual Product]
   719 E C0037088:Finding [Sign or Symptom]
   719 E C0243095:Finding [Finding]
   719 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "consistent with the conclusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a first stage of clinical amyloid nephropathy"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0441766:First stage [Intellectual Product]
   774   C0205563:Clinical stage [Temporal Concept]
   748   C0205390:Stage [Temporal Concept]
   748   C0205435:First [Quantitative Concept]
   748   C1279901:First [Qualitative Concept]
   748   C1300072:Stage [Clinical Attribute]
   748   C1306673:Stage [Qualitative Concept]

Phrase: "and"

Phrase: "could"

Phrase: "be"

Phrase: "premonitory of neuropathy."
Processing 00000000.tx.167: Elevated levels of urinary albumin appeared during the first years of FAP, disclosing a subpopulation with higher risk of developing renal disease. 

Phrase: "Elevated levels of urinary albumin"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   797   C0243173:urinary levels [Functional Concept]
   797   C0428519:albumin levels [Laboratory or Test Result]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "appeared during the first years of FAP,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   790   C0206245:Familial amyloid polyneuropathy [Disease or Syndrome]
   790   C2751492:AMYLOID POLYNEUROPATHY, FAMILIAL [Disease or Syndrome]
   764   C0206247:Amyloid polyneuropathy [Disease or Syndrome]
   762   C0751448:Polyneuropathy, Familial [Disease or Syndrome]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0015576:familial [Family Group]
   742   C0152025:Polyneuropathy [Disease or Syndrome]
   742   C0205435:First [Quantitative Concept]
   742   C0241888:Familial [Functional Concept]
   742   C0439234:years [Temporal Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1279901:First [Qualitative Concept]
   708 E C0439508:/year [Temporal Concept]
   708   C0700364:APPEAR [Qualitative Concept]

Phrase: "disclosing"

Phrase: "a subpopulation with higher risk of developing renal disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1257890:Subpopulation [Population Group]
Processing 00000000.tx.168: Liver transplantation currently appears to be the only treatment for FAP, and should be performed during the early phases of disease. 

Phrase: "Liver transplantation currently"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0023911:Liver Transplantation [Therapeutic or Preventive Procedure]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   827   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   827   C0040733:transplantation [Functional Concept]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the only treatment for FAP,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "should"

Phrase: "be"

Phrase: "performed during the early phases of disease."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   774   C0457338:Disease phases [Temporal Concept]
   774   C0679245:early disease [Temporal Concept]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0585064:Phases [Temporal Concept]
   748   C0884358:Performed [Functional Concept]
   748   C1067936:Phasis [Eukaryote]
   748   C1279919:Early [Temporal Concept]
   714 E C0205390:Phase [Temporal Concept]
   714 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.169: The organ damage caused by amyloid seems to be irreversible, and the mortality and morbidity for patients transplanted in later stages are unacceptably high [24]. 

Phrase: "The organ damage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010957:Damage [Injury or Poisoning]
   861   C0178784:Organ [Body Part, Organ, or Organ Component]
   861   C1883709:Damage [Functional Concept]

Phrase: "caused by amyloid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "irreversible,"

Phrase: "and"

Phrase: "the mortality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026565:Mortality [Quantitative Concept]
  1000   C0026566:mortality [Quantitative Concept]

Phrase: "and"

Phrase: "morbidity for patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026538:Morbidity [Quantitative Concept]
   790   C0220880:morbidity [Intellectual Product]

Phrase: "transplanted in later stages"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   816   C1279941:late stages [Temporal Concept]
   770   C0040732:transplanted [Therapeutic or Preventive Procedure]
   770   C0332835:transplanted [Tissue]
   770   C0700106:Transplanted [Functional Concept]
   770   C1306673:Stages [Qualitative Concept]
   737   C0205087:Late [Temporal Concept]
   737 E C0205390:Stage [Temporal Concept]
   737 E C1300072:Stage [Clinical Attribute]

Phrase: "are"

Phrase: "unacceptably high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "[24"

Phrase: "]."
Processing 00000000.tx.170: Screening for microalbuminuria may be important for therapeutic decisions in individuals at risk, identifying who will benefit from early liver transplantation. 

Phrase: "Screening for microalbuminuria"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0220908:Screening [Health Care Activity]
   790   C0220909:screening [Functional Concept]
   790   C1698960:screening [Intellectual Product]
   790   C1710031:Screening [Diagnostic Procedure]
   790   C1710477:SCREENING [Research Activity]

Phrase: "may"

Phrase: "be"

Phrase: "important for therapeutic decisions"

Phrase: "in individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "at risk,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1444641:At risk [Qualitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C1516077:At [Spatial Concept]

Phrase: "identifying"

Phrase: "who"

Phrase: "will"

Phrase: "benefit from early liver transplantation."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C0023911:Liver Transplantation [Therapeutic or Preventive Procedure]
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   760   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   760   C0040733:transplantation [Functional Concept]
   760   C0736268:LIVER [Body Part, Organ, or Organ Component]
   760   C0814225:Benefit [Quantitative Concept]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C1279919:Early [Temporal Concept]
   760   C2346688:LIVER [Food]
   704 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.171: We recommend the systematic and regular measurement of urinary albumin excretion in asymptomatic gene carriers and patients, instead of renal biopsy, as a non-invasive method for estimating the progression of glomerular transthyretin amyloidosis.  

Phrase: "We"

Phrase: "recommend"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034866:recommend [Idea or Concept]

Phrase: "the systematic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220922:systematic [Functional Concept]

Phrase: "and"

Phrase: "regular measurement of urinary albumin excretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0201808:Excretion measurement [Laboratory Procedure]
   783   C0201838:Albumin measurement [Laboratory Procedure]
   753   C0242485:Measurement [Functional Concept]

Phrase: "in asymptomatic gene carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0007294:carriers [Finding]
   793 E C0560175:Carrier [Finding]
   793 E C1706209:Carrier [Medical Device]
   793 E C3273162:Carrier [Intellectual Product]

Phrase: "and"

Phrase: "patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "instead of renal biopsy,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0194073:Renal biopsy [Diagnostic Procedure]
   861   C0005558:Biopsy [Diagnostic Procedure]
   861   C0220797:biopsy [Functional Concept]

Phrase: "as"

Phrase: "a non-invasive method for estimating"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]

Phrase: "the progression of glomerular transthyretin amyloidosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0242656:progression [Pathologic Function]
   753   C0449258:Progression [Functional Concept]
Processing 00000000.tx.172: Acknowledgments  This study was supported by grant 257/97 from the Ministry of Health, Comisso de Fomento para a Investigao. 

Phrase: "Acknowledgments"

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "supported by grant 257/97"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0018173:Grant [Quantitative Concept]
   760   C0439073:97 [Intellectual Product]
   760   C0439082:>97 [Quantitative Concept]
   760   C1521721:Supported [Conceptual Entity]
   760   C1548284:Grant [Idea or Concept]
   726 E C0183683:Support [Medical Device]

Phrase: "from the Ministry of Health,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0018684:Health [Idea or Concept]
   727 E C0031206:healthiness [Finding]

Phrase: "Comisso de Fomento para"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030563:Para [Finding]

Phrase: "a Investigao."
Processing 00000000.tx.173: The authors wish to thank Mrs Teresa Barandela and Mr Carlos Gouveia for their technical support in the immunohistochemistry of renal biopsies.  

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "wish"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1423524:WISH [Gene or Genome]
  1000   C3273411:WISH [Gene or Genome]
  1000   C3273412:WISH [Amino Acid, Peptide, or Protein]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Mrs Teresa Barandela"

Phrase: "and"

Phrase: "Mr Carlos Gouveia for their technical support"

Phrase: "in the immunohistochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "of renal biopsies."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0194073:Renal biopsy [Diagnostic Procedure]
   861   C0005558:biopsies [Diagnostic Procedure]
   827 E C0220797:biopsy [Functional Concept]
Processing 00000000.tx.174: Notes  Correspondence and offprint requests to: Lusa Lobato, MD, Centro de Estudos de Paramiloidose, Hospital Geral de Santo Antnio, Rua D. 

Phrase: "Notes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "Correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "offprint"

Phrase: "requests"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0686900:request [Functional Concept]
  1000   C1272683:Request [Functional Concept]
  1000   C1522634:Request [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: ":"

Phrase: "Lusa Lobato,"

Phrase: "MD,"

Phrase: "Centro de Estudos de Paramiloidose,"

Phrase: "Hospital Geral de Santo Antnio,"

Phrase: "Rua D."
Processing 00000000.tx.175: Manuel II, 4050-345 Porto, Portugal Email: llobato{at}netcabo.pt  References Top Abstract Introduction Subjects and methods Results Discussion References  Benson MD. 

Phrase: "Manuel II,"

Phrase: "4050-345 Porto,"

Phrase: "Portugal Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013849:E-Mail [Intellectual Product]
   861   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "llobato{at}netcabo.pt"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Benson MD."
Processing 00000000.tx.176: Polyneuropathie amylide familiale. 

Phrase: "Polyneuropathie amylide familiale."
Processing 00000000.tx.177: In: Grateau G, Benson MD, Delpech M ed. 

Phrase: "In"

Phrase: ":"

Phrase: "Grateau G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Benson MD,"

Phrase: "Delpech M ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538926:ED [Idea or Concept]
Processing 00000000.tx.178: Les Amyloses. 

Phrase: "Les Amyloses."
Processing 00000000.tx.179: Mdecine-Sciences Flammarion, Paris, France:2000;445456 Connors LH, Richardson AM, Thberge R, Costello CE. 

Phrase: "Mdecine-Sciences Flammarion,"

Phrase: "Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ":"

Phrase: "2000"

Phrase: ";445456 Connors LH,"

Phrase: "Richardson"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443048:Richardson [Intellectual Product]

Phrase: "AM"

Phrase: ","

Phrase: "Thberge R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Costello CE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]
Processing 00000000.tx.180: Tabulation of transthyretin (TTR) variants as of 1/1/2000. 

Phrase: "Tabulation of transthyretin"

Phrase: "(TTR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032923:Transthyretin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1421224:TRANSTHYRETIN [Gene or Genome]

Phrase: ")"

Phrase: "variants as of 1/1/2000."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:variants [Qualitative Concept]
Processing 00000000.tx.181: Amyloid: Int J Exp Clin Invest2000; 

Phrase: "Amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "Int J Exp Clin Invest2000"

Phrase: ";"
Processing 00000000.tx.182: 7:5469 Persey M, Booth D, Booth S et al. 

Phrase: "7"

Phrase: ":"

Phrase: "5469 Persey M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Booth D,"

Phrase: "Booth S et al."
Processing 00000000.tx.183: Hereditary nephropathic systemic amyloidosis caused by a novel variant apolipoprotein A-1. 

Phrase: "Hereditary nephropathic systemic amyloidosis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C0206246:Amyloidosis, Hereditary [Disease or Syndrome]
   875   C0268382:Nephropathic amyloidosis [Disease or Syndrome]
   861   C0268380:Systemic amyloidosis [Disease or Syndrome]
   861   C0268381:AMYLOIDOSIS, SYSTEMIC [Disease or Syndrome]
   861   C0281479:Systemic Amyloidosis [Neoplastic Process]
   812   C0002726:Amyloidosis [Disease or Syndrome]

Phrase: "caused by a novel variant apolipoprotein A-1."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C0085201:Apolipoprotein A-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0003592:Apolipoprotein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205314:Novel [Temporal Concept]
   744   C0205419:Variant [Qualitative Concept]
   744   C0679622:novel [Intellectual Product]
   711   C0015127:cause [Functional Concept]
   711   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.184: Kidney Int1998; 

Phrase: "Kidney Int1998"

Phrase: ";"
Processing 00000000.tx.185: 53:276281[ISI][Medline] Benson MD, Liepnieks JJ, Yazaki M et al. 

Phrase: "53"

Phrase: ":"

Phrase: "276281"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Benson MD,"

Phrase: "Liepnieks JJ,"

Phrase: "Yazaki M et al."
Processing 00000000.tx.186: A new human hereditary amyloidosis: the result of a stop-codon mutation in the apolipoprotein AII gene. 

Phrase: "A new human hereditary amyloidosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0206246:Amyloidosis, Hereditary [Disease or Syndrome]
   812   C0002726:Amyloidosis [Disease or Syndrome]
   812   C0439660:Hereditary [Functional Concept]

Phrase: ":"

Phrase: "the result of a stop-codon mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "in the apolipoprotein AII gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1445865:Apolipoprotein gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0085202:Apolipoprotein A-II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.187: Genomics2001; 

Phrase: "Genomics2001"

Phrase: ";"
Processing 00000000.tx.188: 72:272277[CrossRef][ISI][Medline] Uemichi T, Liepnieks JJ, Benson M. 

Phrase: "72"

Phrase: ":"

Phrase: "272277"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Uemichi T,"

Phrase: "Liepnieks JJ,"

Phrase: "Benson M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.189: Hereditary renal amyloidosis with a novel variant fibrinogen. 

Phrase: "Hereditary renal amyloidosis with a novel variant fibrinogen."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0268382:Renal amyloidosis [Disease or Syndrome]
   770   C1416945:renal amyloidosis [Gene or Genome]
   767   C0206246:Amyloidosis, Hereditary [Disease or Syndrome]
   744   C0002726:Amyloidosis [Disease or Syndrome]
Processing 00000000.tx.190: J Clin Invest1994; 

Phrase: "J Clin Invest1994"

Phrase: ";"
Processing 00000000.tx.191: 93:731736[ISI][Medline] Pepys M, Hawkins P, Booth D et al. 

Phrase: "93"

Phrase: ":"

Phrase: "731736"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pepys M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hawkins P,"

Phrase: "Booth D et al."
Processing 00000000.tx.192: Human lysosyme gene mutations cause hereditary systemic amyloidosis. 

Phrase: "Human lysosyme gene mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   875   C0314604:Human gene [Gene or Genome]
   861   C0596611:gene mutations [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "hereditary systemic amyloidosis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0206246:Amyloidosis, Hereditary [Disease or Syndrome]
   901   C0268380:Systemic amyloidosis [Disease or Syndrome]
   901   C0268381:AMYLOIDOSIS, SYSTEMIC [Disease or Syndrome]
   901   C0281479:Systemic Amyloidosis [Neoplastic Process]
   827   C0002726:Amyloidosis [Disease or Syndrome]
Processing 00000000.tx.193: Nature1993; 

Phrase: "Nature1993"

Phrase: ";"
Processing 00000000.tx.194: 362:553557[CrossRef][ISI][Medline] Maury C. 

Phrase: "362"

Phrase: ":"

Phrase: "553557"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Maury C."
Processing 00000000.tx.195: Homozygous familial amyloidosis, Finish type: demonstration of glomerular gelsolin-derived amyloid and non-amyloid tubular gelsolin. 

Phrase: "Homozygous familial amyloidosis,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0740340:Amyloidosis, Familial [Disease or Syndrome]
   827   C0002726:Amyloidosis [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "Finish type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ":"

Phrase: "demonstration of glomerular gelsolin-derived amyloid"

Phrase: "and"

Phrase: "non-amyloid tubular gelsolin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0061187:Gelsolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1415323:GELSOLIN [Gene or Genome]
Processing 00000000.tx.196: Clin Nephrol 1991;4053 Pras M. 

Phrase: "Clin Nephrol 1991"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1315013:CLIN [Intellectual Product]

Phrase: ";4053 Pras M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.197: Amyloidosis of familial Mediterranean fever and the MEFV gene. 

Phrase: "Amyloidosis of familial Mediterranean fever"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0740340:Amyloidosis, Familial [Disease or Syndrome]
   760   C0002726:Amyloidosis [Disease or Syndrome]

Phrase: "and"

Phrase: "the MEFV gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417104:MEFV gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.198: Amyloid: Int J Exp Clin Invest2000; 

Phrase: "Amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "Int J Exp Clin Invest2000"

Phrase: ";"
Processing 00000000.tx.199: 7:289293 Linke R, Heimann K, Nathrath W, Eulitz M. 

Phrase: "7"

Phrase: ":"

Phrase: "289293 Linke R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "Heimann K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Nathrath W,"

Phrase: "Eulitz M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.200: Identification of amyloid A protein in a sporadic Muckle-Wells syndrome. 

Phrase: "Identification of amyloid A protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "in a sporadic Muckle-Wells syndrome."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0268390:Muckle-Wells Syndrome [Disease or Syndrome]
   923   C2700591:MUCKLE-WELLS SYNDROME [Gene or Genome]
   861   C0343101:Wells syndrome [Disease or Syndrome]
   812   C0039082:Syndrome [Disease or Syndrome]
   779   C0205170:Well [Qualitative Concept]
   779   C3146287:Well [Manufactured Object]
Processing 00000000.tx.201: N-terminal amino acid sequence after isolation from formalin-fixed tissue. 

Phrase: "N-terminal amino acid sequence after isolation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   853   C1706793:N-Terminal Amino Acid [Amino Acid Sequence]
   814   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   778   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C2917660:Amino Acid [Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0202406:Acid [Laboratory Procedure]
   748   C1519249:Sequence [Functional Concept]

Phrase: "from formalin-fixed tissue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040300:Tissue [Tissue]
   827   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.202: Lab Invest1983; 

Phrase: "Lab Invest1983"

Phrase: ";"
Processing 00000000.tx.203: 48:698704[ISI][Medline] McDermott MF, Aksentijevich I, Galon J et al. 

Phrase: "48"

Phrase: ":"

Phrase: "698704"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McDermott MF,"

Phrase: "Aksentijevich I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Galon J et al."
Processing 00000000.tx.204: Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. 

Phrase: "Germline mutations in the extracellular domains of the 55 kDa TNF receptor,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0206530:Mutations, Germ-Line [Genetic Function]
   736   C0017473:Germ Line [Cell]
   736   C0026882:Mutations [Genetic Function]
   719 E C1705427:Germline Mutation [Cell or Molecular Dysfunction]
   703 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "TNFR1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0255808:TNFR-I [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1363984:TNFR1 [Gene or Genome]
  1000   C1706001:TNFR1 [Gene or Genome]

Phrase: "define"

Phrase: "a family of dominantly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015576:Family [Family Group]
   770   C1704727:Family [Conceptual Entity]

Phrase: "inherited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439660:Inherited [Functional Concept]

Phrase: "autoinflammatory syndromes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039082:Syndromes [Disease or Syndrome]
   861   C1558916:SYNDROMES [Finding]
Processing 00000000.tx.205: Cell1999; 

Phrase: "Cell1999"

Phrase: ";"
Processing 00000000.tx.206: 97:133144[ISI][Medline] Jadoul M, Dod C, Cosyns JP et al. 

Phrase: "97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: ":"

Phrase: "133144"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jadoul M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Dod C,"

Phrase: "Cosyns JP et al."
Processing 00000000.tx.207: Autosomal-dominant periodic fever with AA amyloidosis: Novel mutation in tumor necrosis factor receptor 1 gene. 

Phrase: "Autosomal-dominant periodic fever with AA amyloidosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0015974:Periodic fever [Disease or Syndrome]
   748   C0015967:Fever [Finding]
   748   C0332182:Periodic [Temporal Concept]
   748   C1706381:PERIODIC [Intellectual Product]

Phrase: ":"

Phrase: "Novel mutation in tumor necrosis factor receptor 1 gene."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C2985438:Novel Mutation [Cell or Molecular Dysfunction]
   762   C0596611:Gene Mutation [Genetic Function]
   742   C0026882:Mutation [Genetic Function]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.208: Kidney Int2001; 

Phrase: "Kidney Int2001"

Phrase: ";"
Processing 00000000.tx.209: 59:16771682[CrossRef][ISI][Medline] Shokeir AA, Moustafa FE, Enein HA, Donia AF, Ghoneim MA. 

Phrase: "59"

Phrase: ":"

Phrase: "16771682"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shokeir AA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "Moustafa FE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346593:Fe+++ [Element, Ion, or Isotope]

Phrase: "Enein HA,"

Phrase: "Donia AF,"

Phrase: "Ghoneim MA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0730345:Microalbuminuria [Disease or Syndrome]
Processing 00000000.tx.210: Renal amyloidosis without urinary abnormality in a potential live-kidney donor. 

Phrase: "Renal amyloidosis without urinary abnormality"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0268382:Renal amyloidosis [Disease or Syndrome]
   806   C1416945:renal amyloidosis [Gene or Genome]
   760   C0002726:Amyloidosis [Disease or Syndrome]

Phrase: "in a potential live-kidney donor."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0348050:Live donor [Population Group]
   861   C0260788:Kidney donor [Population Group]
   861   C1313935:Kidney donor [Finding]
   812   C0013018:Donor [Population Group]
   812   C0040288:Donor [Population Group]
   812   C1527169:Donor NOS [Finding]
Processing 00000000.tx.211: Nephrol Dial Transplant1996; 

Phrase: "Nephrol Dial Transplant1996"

Phrase: ";"
Processing 00000000.tx.212: 9:13391340[ISI][Medline] Holmgren G, Ericzon BG, Groth CG et al. 

Phrase: "9"

Phrase: ":"

Phrase: "13391340"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Holmgren G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Ericzon BG,"

Phrase: "Groth CG et al."
Processing 00000000.tx.213: Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. 

Phrase: "Clinical improvement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986411:Improvement [Conceptual Entity]

Phrase: "and"

Phrase: "amyloid regression after liver transplantation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0684320:Regression [Pathologic Function]
   760   C0684321:Regression [Mental Process]

Phrase: "in hereditary transthyretin amyloidosis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0206246:Amyloidosis, Hereditary [Disease or Syndrome]
   901   C0268407:transthyretin amyloidosis [Disease or Syndrome]
   901   C2751492:Transthyretin Amyloidosis [Disease or Syndrome]
   827   C0002726:Amyloidosis [Disease or Syndrome]
Processing 00000000.tx.214: Lancet1993; 

Phrase: "Lancet1993"

Phrase: ";"
Processing 00000000.tx.215: 341:11131116[ISI][Medline] Lobato L, Beiro I, Monteiro P, Saraiva MJM, Coelho T, Sousa A. 

Phrase: "341"

Phrase: ":"

Phrase: "11131116"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lobato L,"

Phrase: "Beiro I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Monteiro P,"

Phrase: "Saraiva MJM,"

Phrase: "Coelho T,"

Phrase: "Sousa A."
Processing 00000000.tx.216: Epidemiology and genetic analysis in patients with familial amyloid polyneuropathy (FAP): can we predict renal involvement? 

Phrase: "Epidemiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014507:Epidemiology [Biomedical Occupation or Discipline]
  1000   C0014508:epidemiology [Functional Concept]
  1000   C0699910:epidemiology [Health Care Activity]

Phrase: "and"

Phrase: "genetic analysis in patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0679560:genetic analysis [Laboratory Procedure]
   833   C0796344:Genetic Analysis [Laboratory Procedure]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "with familial amyloid polyneuropathy"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0206245:Familial amyloid polyneuropathy [Disease or Syndrome]
  1000   C2751492:AMYLOID POLYNEUROPATHY, FAMILIAL [Disease or Syndrome]
   913   C0751448:Polyneuropathy, Familial [Disease or Syndrome]
   901   C0206247:Amyloid polyneuropathy [Disease or Syndrome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0015576:familial [Family Group]
   827   C0152025:Polyneuropathy [Disease or Syndrome]
   827   C0241888:Familial [Functional Concept]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "(FAP"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0206245:Familial amyloid polyneuropathy [Disease or Syndrome]
  1000   C2751492:AMYLOID POLYNEUROPATHY, FAMILIAL [Disease or Syndrome]
   913   C0751448:Polyneuropathy, Familial [Disease or Syndrome]
   901   C0206247:Amyloid polyneuropathy [Disease or Syndrome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0015576:familial [Family Group]
   827   C0152025:Polyneuropathy [Disease or Syndrome]
   827   C0241888:Familial [Functional Concept]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   755 E C1704727:Family [Conceptual Entity]

Phrase: ")"

Phrase: ":"

Phrase: "can"

Phrase: "we"

Phrase: "predict"

Phrase: "renal involvement?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1314939:Involvement [Functional Concept]
Processing 00000000.tx.217: Neuromusc Disord 1996; 

Phrase: "Neuromusc Disord 1996"

Phrase: ";"
Processing 00000000.tx.218: [Suppl] 6:S51. 

Phrase: "[Suppl] 6"

Phrase: ":"

Phrase: "S51."
Processing 00000000.tx.219: Lobato L, Beiro B, Guimares SM et al. 

Phrase: "Lobato L,"

Phrase: "Beiro B,"

Phrase: "Guimares SM et al."
Processing 00000000.tx.220: Familial amyloid polyneuropathy type I (Portuguese) distribution and characterization of renal amyloid deposits. 

Phrase: "Familial amyloid polyneuropathy type I (Portuguese"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0032730:Portuguese [Population Group]
   734   C0268384:Amyloid polyneuropathy type I [Disease or Syndrome]

Phrase: ")"

Phrase: "distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520511:distribution [Idea or Concept]
  1000   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "characterization of renal amyloid deposits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]
Processing 00000000.tx.221: Am J Kidney Dis1998; 

Phrase: "Am"

Phrase: "J Kidney Dis1998"

Phrase: ";"
Processing 00000000.tx.222: 6:940946 Costa PMP. 

Phrase: "6"

Phrase: ":"

Phrase: "940946 Costa PMP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678075:PMP [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.223: Amiloidoses transtirretinicas, da biopatologia  teraputica. 

Phrase: "Amiloidoses transtirretinicas,"

Phrase: "da biopatologia  teraputica."
Processing 00000000.tx.224: Porto University Medical Dissertation. 

Phrase: "Porto University Medical Dissertation."
Processing 00000000.tx.225: 1993; 

Phrase: "1993"

Phrase: ";"
Processing 00000000.tx.226: 7477 Choukroun G, Goupy CH, Nol LH, Droz D, Grnfeld JP. 

Phrase: "7477 Choukroun G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Goupy CH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0558269:Ch. [Professional or Occupational Group]
   861   C1552984:[Ch] [Quantitative Concept]

Phrase: "Nol LH,"

Phrase: "Droz D,"

Phrase: "Grnfeld JP."
Processing 00000000.tx.227: Amylose du rein et de l'appareil urinaire. 

Phrase: "Amylose du rein et de l'appareil urinaire."
Processing 00000000.tx.228: In: Grateau G, Benson MD, Delpech M ed. 

Phrase: "In"

Phrase: ":"

Phrase: "Grateau G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Benson MD,"

Phrase: "Delpech M ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538926:ED [Idea or Concept]
Processing 00000000.tx.229: Les Amyloses. 

Phrase: "Les Amyloses."
Processing 00000000.tx.230: Mdecine-Sciences Flammarion, Paris, France:2000;163177 Vaamonde C, Prez G, Pardo V. 

Phrase: "Mdecine-Sciences Flammarion,"

Phrase: "Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ":"

Phrase: "2000"

Phrase: ";163177 Vaamonde C,"

Phrase: "Prez G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Pardo V."
Processing 00000000.tx.231: Dysproteinemias: multiple myeloma, amyloidosis and related disorders. 

Phrase: "Dysproteinemias"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0259744:dysproteinemias [Disease or Syndrome]

Phrase: ":"

Phrase: "multiple myeloma,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]

Phrase: "amyloidosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002726:Amyloidosis [Disease or Syndrome]

Phrase: "and"

Phrase: "related disorders."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.232: In: Schrier R, Gottschalk C ed. 

Phrase: "In"

Phrase: ":"

Phrase: "Schrier R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Gottschalk C ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538926:ED [Idea or Concept]
Processing 00000000.tx.233: Diseases of the Kidney, 5th edn. 

Phrase: "Diseases of the Kidney,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   870   C0022658:Disease of kidney [Disease or Syndrome]
           Kidney Diseases
   770   C0012634:Diseases [Disease or Syndrome]

Phrase: "5th edn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419408:EDN [Gene or Genome]
Processing 00000000.tx.234: Little, Brown, Boston, MA:1992;21892237 Mogensen CE. 

Phrase: "Little, Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: ":"

Phrase: "1992"

Phrase: ";21892237 Mogensen CE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827664:CE [Idea or Concept]
Processing 00000000.tx.235: Microalbuminuria as a predictor of clinical diabetic nephropathy. 

Phrase: "Microalbuminuria as a predictor of clinical diabetic nephropathy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0403518:Microalbuminuric diabetic nephropathy [Disease or Syndrome]
   744   C0730345:Microalbuminuria [Disease or Syndrome]
Processing 00000000.tx.236: Kidney Int1987; 

Phrase: "Kidney Int1987"

Phrase: ";"
Processing 00000000.tx.237: 31:673689[ISI][Medline] sterby R, Parving HH, Hommel E, Jorgensen HE, Lkkegaard. 

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ":"

Phrase: "673689"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] sterby R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Parving HH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0062941:HH [Organic Chemical,Pharmacologic Substance]
   861   C1384665:HH [Gene or Genome]
   861   C1414862:Hh [Gene or Genome]

Phrase: "Hommel E,"

Phrase: "Jorgensen"

Phrase: "HE,"

Phrase: "Lkkegaard."
Processing 00000000.tx.238: Glomerular structure and function in diabetic nephropathy. 

Phrase: "Glomerular structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   964   C0022663:Glomerulus structure [Body Part, Organ, or Organ Component]
   861   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "function in diabetic nephropathy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]
Processing 00000000.tx.239: Early to advanced stages. 

Phrase: "Early to advanced stages."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   819   C2363430:early stages [Temporal Concept]
   802 E C1517886:Early Stage [Classification]
   770   C0205179:Advanced [Qualitative Concept]
   770   C1279919:Early [Temporal Concept]
   770   C1306673:Stages [Qualitative Concept]
   737 E C0205390:Stage [Temporal Concept]
   737 E C0725066:Advance [Medical Device]
   737 E C1300072:Stage [Clinical Attribute]
Processing 00000000.tx.240: Diabetes1990; 

Phrase: "Diabetes1990"

Phrase: ";"
Processing 00000000.tx.241: 39:10571063[Abstract] Campese Vito M, Bianchi S, Bigazzi R. 

Phrase: "39"

Phrase: ":"

Phrase: "10571063"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Campese Vito M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Bianchi S,"

Phrase: "Bigazzi R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.242: Association between hyperlipidemia and microalbuminuria in essential hypertension. 

Phrase: "Association between hyperlipidemia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "microalbuminuria in essential hypertension."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0730345:Microalbuminuria [Disease or Syndrome]
Processing 00000000.tx.243: Kidney Int 1999; 

Phrase: "Kidney Int 1999"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0022646:Kidney [Body Part, Organ, or Organ Component]
   827   C0063789:INT [Organic Chemical]
   827   C0227665:kidney [Body Part, Organ, or Organ Component]
   827   C1278978:Kidney [Body Part, Organ, or Organ Component]
   827   C1514845:KIDNEY [Tissue]
   827   C3272375:INT [Intellectual Product]
   734 E C0027697:Nephritides [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.244: 56 [Suppl] 71:S10S13[CrossRef][ISI] Axelrod FB, Glickstein JS, Weider J, Gluck MC, Friedman D. 

Phrase: "56"

Phrase: "[Suppl] 71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450389:71 [Intellectual Product]

Phrase: ":"

Phrase: "S10S13"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI] Axelrod FB,"

Phrase: "Glickstein JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Weider J,"

Phrase: "Gluck MC,"

Phrase: "Friedman D."
Processing 00000000.tx.245: The effects of postural change and exercise on renal haemodynamics in familial dysautonomia. 

Phrase: "The effects of postural change"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "exercise on renal haemodynamics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015259:Exercise [Daily or Recreational Activity]
   770   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "in familial dysautonomia."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0013364:Dysautonomia, Familial [Congenital Abnormality,Disease or Syndrome]
   861   C0013363:Dysautonomia [Disease or Syndrome]
   861   C0015576:familial [Family Group]
   861   C0241888:Familial [Functional Concept]
   861   C1145628:dysautonomia [Disease or Syndrome]
   789 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.246: Clin Auton Res1993; 

Phrase: "Clin Auton Res1993"

Phrase: ";"
Processing 00000000.tx.247: 3:195200[Medline] Pearson J, Gallo G, Gluck M, Axelrod F. 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "195200"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pearson J,"

Phrase: "Gallo G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Gluck M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Axelrod F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.248: Renal disease in familial dysautonomia. 

Phrase: "Renal disease in familial dysautonomia."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   806   C0022658:Renal disease [Disease or Syndrome]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0022646:Renal [Body Part, Organ, or Organ Component]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.249: Kidney Int1980; 

Phrase: "Kidney Int1980"

Phrase: ";"
Processing 00000000.tx.250: 17:102112[ISI][Medline] Suhr OB, Herlenius G, Friman S, Ericzon BG. 

Phrase: "17"

Phrase: ":"

Phrase: "102112"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Suhr OB,"

Phrase: "Herlenius G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Friman S,"

Phrase: "Ericzon BG."
Processing 00000000.tx.251: Liver transplantation for transthyretin amyloidosis. 

Phrase: "Liver transplantation for transthyretin amyloidosis."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0023911:Liver Transplantation [Therapeutic or Preventive Procedure]
   797   C0267839:amyloidosis liver [Disease or Syndrome]
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   760   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   760   C0040733:transplantation [Functional Concept]
   760   C0736268:LIVER [Body Part, Organ, or Organ Component]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C2346688:LIVER [Food]
   704 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.252: Liver Transplant2000; 

Phrase: "Liver Transplant2000"

Phrase: ";"
Processing 00000000.tx.253: 6:263276[ISI][Medline] Received for publication: 28. 

Phrase: "6"

Phrase: ":"

Phrase: "263276"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "Received for publication"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: ":"

Phrase: "28."
Processing 00000000.tx.254: 9.01 Accepted in revised form: 17. 

Phrase: "9.01"

Phrase: "Accepted in revised form"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1272684:Accepted [Qualitative Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]
   770   C1548435:Accepted [Idea or Concept]
   737 E C1548601:Accept [Idea or Concept]

Phrase: ":"

Phrase: "17."
Processing 00000000.tx.255: 9.02

Phrase: "9.02"

